AU2021224551A1 - AAV capsid-promoter interactions and cell selective gene expression - Google Patents

Info

Publication number

AU2021224551A1

AU2021224551A1 AU2021224551A AU2021224551A AU2021224551A1 AU 2021224551 A1 AU2021224551 A1 AU 2021224551A1 AU 2021224551 A AU2021224551 A AU 2021224551A AU 2021224551 A AU2021224551 A AU 2021224551A AU 2021224551 A1 AU2021224551 A1 AU 2021224551A1

Authority

AU

Australia

Prior art keywords

promoter

aav

amino acid

capsid protein

cell

Prior art date

2020-02-18

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• Discuss

• 230000014509 gene expression Effects 0.000 title claims description 163
• 230000003993 interaction Effects 0.000 title description 9
• 108090000565 Capsid Proteins Proteins 0.000 claims abstract description 187
• 102100023321 Ceruloplasmin Human genes 0.000 claims abstract description 186
• 239000002245 particle Substances 0.000 claims abstract description 158
• 238000000034 method Methods 0.000 claims abstract description 144
• 210000004027 cell Anatomy 0.000 claims description 286
• 150000007523 nucleic acids Chemical class 0.000 claims description 172
• 102000039446 nucleic acids Human genes 0.000 claims description 160
• 108020004707 nucleic acids Proteins 0.000 claims description 160
• 150000001413 amino acids Chemical group 0.000 claims description 157
• 239000013598 vector Substances 0.000 claims description 133
• 235000001014 amino acid Nutrition 0.000 claims description 126
• 108090000623 proteins and genes Proteins 0.000 claims description 120
• 229940024606 amino acid Drugs 0.000 claims description 119
• 241000700605 Viruses Species 0.000 claims description 118
• 230000004048 modification Effects 0.000 claims description 117
• 238000012986 modification Methods 0.000 claims description 117
• 210000000234 capsid Anatomy 0.000 claims description 98
• 230000001939 inductive effect Effects 0.000 claims description 76
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 72
• 238000003780 insertion Methods 0.000 claims description 71
• 230000037431 insertion Effects 0.000 claims description 71
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 70
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 67
• 102000004169 proteins and genes Human genes 0.000 claims description 66
• 229920001184 polypeptide Polymers 0.000 claims description 65
• 235000018102 proteins Nutrition 0.000 claims description 59
• 210000002569 neuron Anatomy 0.000 claims description 48
• 230000003612 virological effect Effects 0.000 claims description 42
• 108700019146 Transgenes Proteins 0.000 claims description 39
• 108091023040 Transcription factor Proteins 0.000 claims description 37
• 102000040945 Transcription factor Human genes 0.000 claims description 36
• 241000701161 unidentified adenovirus Species 0.000 claims description 34
• 239000013607 AAV vector Substances 0.000 claims description 33
• 241000701022 Cytomegalovirus Species 0.000 claims description 33
• 241000125945 Protoparvovirus Species 0.000 claims description 33
• 102000040430 polynucleotide Human genes 0.000 claims description 33
• 108091033319 polynucleotide Proteins 0.000 claims description 33
• 239000002157 polynucleotide Substances 0.000 claims description 33
• 210000003169 central nervous system Anatomy 0.000 claims description 32
• 208000035475 disorder Diseases 0.000 claims description 30
• -1 phage Substances 0.000 claims description 30
• 239000013603 viral vector Substances 0.000 claims description 29
• 125000000539 amino acid group Chemical group 0.000 claims description 28
• 241000702423 Adeno-associated virus - 2 Species 0.000 claims description 27
• 210000001519 tissue Anatomy 0.000 claims description 27
• 239000004098 Tetracycline Substances 0.000 claims description 26
• 229960002180 tetracycline Drugs 0.000 claims description 26
• 229930101283 tetracycline Natural products 0.000 claims description 26
• 235000019364 tetracycline Nutrition 0.000 claims description 26
• 150000003522 tetracyclines Chemical class 0.000 claims description 26
• 241000282414 Homo sapiens Species 0.000 claims description 24
• 210000004248 oligodendroglia Anatomy 0.000 claims description 24
• 230000001105 regulatory effect Effects 0.000 claims description 24
• 108091030071 RNAI Proteins 0.000 claims description 23
• 230000009368 gene silencing by RNA Effects 0.000 claims description 23
• 230000007423 decrease Effects 0.000 claims description 22
• 230000006870 function Effects 0.000 claims description 22
• 238000012384 transportation and delivery Methods 0.000 claims description 22
• 238000006467 substitution reaction Methods 0.000 claims description 21
• 230000001225 therapeutic effect Effects 0.000 claims description 21
• 238000000338 in vitro Methods 0.000 claims description 20
• 108020005544 Antisense RNA Proteins 0.000 claims description 18
• 239000003184 complementary RNA Substances 0.000 claims description 18
• 238000012217 deletion Methods 0.000 claims description 18
• 230000037430 deletion Effects 0.000 claims description 18
• 239000008194 pharmaceutical composition Substances 0.000 claims description 18
• 230000001419 dependent effect Effects 0.000 claims description 15
• 210000004185 liver Anatomy 0.000 claims description 15
• 210000004498 neuroglial cell Anatomy 0.000 claims description 15
• 239000013608 rAAV vector Substances 0.000 claims description 15
• 108010069091 Dystrophin Proteins 0.000 claims description 14
• 239000002679 microRNA Substances 0.000 claims description 14
• 230000007935 neutral effect Effects 0.000 claims description 14
• 241001164825 Adeno-associated virus - 8 Species 0.000 claims description 13
• 108700011259 MicroRNAs Proteins 0.000 claims description 13
• 102000012288 Phosphopyruvate Hydratase Human genes 0.000 claims description 13
• 108010022181 Phosphopyruvate Hydratase Proteins 0.000 claims description 13
• 102000006601 Thymidine Kinase Human genes 0.000 claims description 13
• 108020004440 Thymidine kinase Proteins 0.000 claims description 13
• 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 claims description 13
• 241001529453 unidentified herpesvirus Species 0.000 claims description 13
• 108091026890 Coding region Proteins 0.000 claims description 12
• 230000002378 acidificating effect Effects 0.000 claims description 12
• 208000015181 infectious disease Diseases 0.000 claims description 12
• 108010079892 phosphoglycerol kinase Proteins 0.000 claims description 12
• 239000003623 enhancer Substances 0.000 claims description 11
• 230000035772 mutation Effects 0.000 claims description 11
• 102000001039 Dystrophin Human genes 0.000 claims description 10
• 102000007981 Ornithine carbamoyltransferase Human genes 0.000 claims description 10
• 101710198224 Ornithine carbamoyltransferase, mitochondrial Proteins 0.000 claims description 10
• 239000013612 plasmid Substances 0.000 claims description 10
• 241001655883 Adeno-associated virus - 1 Species 0.000 claims description 9
• 101000834253 Gallus gallus Actin, cytoplasmic 1 Proteins 0.000 claims description 9
• 102000001435 Synapsin Human genes 0.000 claims description 9
• 108050009621 Synapsin Proteins 0.000 claims description 9
• 102000013529 alpha-Fetoproteins Human genes 0.000 claims description 9
• 108010026331 alpha-Fetoproteins Proteins 0.000 claims description 9
• 210000000988 bone and bone Anatomy 0.000 claims description 9
• 239000003937 drug carrier Substances 0.000 claims description 9
• 241000202702 Adeno-associated virus - 3 Species 0.000 claims description 8
• 241001634120 Adeno-associated virus - 5 Species 0.000 claims description 8
• 108010088751 Albumins Proteins 0.000 claims description 8
• 102000009027 Albumins Human genes 0.000 claims description 8
• 241000701959 Escherichia virus Lambda Species 0.000 claims description 8
• 108010004889 Heat-Shock Proteins Proteins 0.000 claims description 8
• 102000002812 Heat-Shock Proteins Human genes 0.000 claims description 8
• 241000700721 Hepatitis B virus Species 0.000 claims description 8
• 101000837639 Homo sapiens Thyroxine-binding globulin Proteins 0.000 claims description 8
• 102100037935 Polyubiquitin-C Human genes 0.000 claims description 8
• 241000714474 Rous sarcoma virus Species 0.000 claims description 8
• 102100028709 Thyroxine-binding globulin Human genes 0.000 claims description 8
• 108010056354 Ubiquitin C Proteins 0.000 claims description 8
• 102000015395 alpha 1-Antitrypsin Human genes 0.000 claims description 8
• 108010050122 alpha 1-Antitrypsin Proteins 0.000 claims description 8
• 229940024142 alpha 1-antitrypsin Drugs 0.000 claims description 8
• 241000972680 Adeno-associated virus - 6 Species 0.000 claims description 7
• 241001164823 Adeno-associated virus - 7 Species 0.000 claims description 7
• 241000649045 Adeno-associated virus 10 Species 0.000 claims description 7
• 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 claims description 7
• WHUUTDBJXJRKMK-VKHMYHEASA-L glutamate group Chemical group N[C@@H](CCC(=O)[O-])C(=O)[O-] WHUUTDBJXJRKMK-VKHMYHEASA-L 0.000 claims description 7
• DODQJNMQWMSYGS-QPLCGJKRSA-N 4-[(z)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-phenylbut-1-en-2-yl]phenol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 DODQJNMQWMSYGS-QPLCGJKRSA-N 0.000 claims description 6
• 241000580270 Adeno-associated virus - 4 Species 0.000 claims description 6
• 241000649046 Adeno-associated virus 11 Species 0.000 claims description 6
• 241000300529 Adeno-associated virus 13 Species 0.000 claims description 6
• 108090000157 Metallothionein Proteins 0.000 claims description 6
• 210000001130 astrocyte Anatomy 0.000 claims description 6
• 241000701447 unidentified baculovirus Species 0.000 claims description 6
• DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 claims description 5
• 101150092506 CCW14 gene Proteins 0.000 claims description 5
• 241000287828 Gallus gallus Species 0.000 claims description 5
• 108060003951 Immunoglobulin Proteins 0.000 claims description 5
• 102000003792 Metallothionein Human genes 0.000 claims description 5
• 208000009869 Neu-Laxova syndrome Diseases 0.000 claims description 5
• 108010077850 Nuclear Localization Signals Proteins 0.000 claims description 5
• 108010005260 S100 Calcium Binding Protein A6 Proteins 0.000 claims description 5
• 241000700584 Simplexvirus Species 0.000 claims description 5
• 108091008874 T cell receptors Proteins 0.000 claims description 5
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 5
• 101150045674 YGP1 gene Proteins 0.000 claims description 5
• 210000004436 artificial bacterial chromosome Anatomy 0.000 claims description 5
• 210000001106 artificial yeast chromosome Anatomy 0.000 claims description 5
• 102000018358 immunoglobulin Human genes 0.000 claims description 5
• NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 claims description 4
• ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 claims description 4
• 102000004657 Calcium-Calmodulin-Dependent Protein Kinase Type 2 Human genes 0.000 claims description 4
• 108010003721 Calcium-Calmodulin-Dependent Protein Kinase Type 2 Proteins 0.000 claims description 4
• 102000014914 Carrier Proteins Human genes 0.000 claims description 4
• 101710163595 Chaperone protein DnaK Proteins 0.000 claims description 4
• 102000004437 G-Protein-Coupled Receptor Kinase 1 Human genes 0.000 claims description 4
• 108091004242 G-Protein-Coupled Receptor Kinase 1 Proteins 0.000 claims description 4
• 101150014889 Gad1 gene Proteins 0.000 claims description 4
• 102100035902 Glutamate decarboxylase 1 Human genes 0.000 claims description 4
• 102100035857 Glutamate decarboxylase 2 Human genes 0.000 claims description 4
• 102000001398 Granzyme Human genes 0.000 claims description 4
• 108060005986 Granzyme Proteins 0.000 claims description 4
• 101710178376 Heat shock 70 kDa protein Proteins 0.000 claims description 4
• 101710152018 Heat shock cognate 70 kDa protein Proteins 0.000 claims description 4
• 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims description 4
• 208000009889 Herpes Simplex Diseases 0.000 claims description 4
• 101000873786 Homo sapiens Glutamate decarboxylase 2 Proteins 0.000 claims description 4
• 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims description 4
• 101000984710 Homo sapiens Lymphocyte-specific protein 1 Proteins 0.000 claims description 4
• 101000979333 Homo sapiens Neurofilament light polypeptide Proteins 0.000 claims description 4
• 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims description 4
• 101000742373 Homo sapiens Vesicular inhibitory amino acid transporter Proteins 0.000 claims description 4
• 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 claims description 4
• 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 claims description 4
• 102000016921 Integrin-Binding Sialoprotein Human genes 0.000 claims description 4
• 108010028750 Integrin-Binding Sialoprotein Proteins 0.000 claims description 4
• 102000003960 Ligases Human genes 0.000 claims description 4
• 108090000364 Ligases Proteins 0.000 claims description 4
• 102100027105 Lymphocyte-specific protein 1 Human genes 0.000 claims description 4
• 108010059343 MM Form Creatine Kinase Proteins 0.000 claims description 4
• 241000713862 Moloney murine sarcoma virus Species 0.000 claims description 4
• 241000713333 Mouse mammary tumor virus Species 0.000 claims description 4
• 101000944608 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Chaperonin GroEL 2 Proteins 0.000 claims description 4
• 102100026057 Myosin regulatory light chain 2, atrial isoform Human genes 0.000 claims description 4
• 101710098224 Myosin regulatory light chain 2, atrial isoform Proteins 0.000 claims description 4
• 102000010175 Opsin Human genes 0.000 claims description 4
• 108050001704 Opsin Proteins 0.000 claims description 4
• 102000004067 Osteocalcin Human genes 0.000 claims description 4
• 108090000573 Osteocalcin Proteins 0.000 claims description 4
• 108010077524 Peptide Elongation Factor 1 Proteins 0.000 claims description 4
• 102000002508 Peptide Elongation Factors Human genes 0.000 claims description 4
• 108010068204 Peptide Elongation Factors Proteins 0.000 claims description 4
• 102000011755 Phosphoglycerate Kinase Human genes 0.000 claims description 4
• 108010064785 Phospholipases Proteins 0.000 claims description 4
• 102000015439 Phospholipases Human genes 0.000 claims description 4
• 108010007131 Pulmonary Surfactant-Associated Protein B Proteins 0.000 claims description 4
• 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims description 4
• 108090000820 Rhodopsin Proteins 0.000 claims description 4
• 108090000799 Rhodopsin kinases Proteins 0.000 claims description 4
• 101001099217 Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) Triosephosphate isomerase Proteins 0.000 claims description 4
• 108010022394 Threonine synthase Proteins 0.000 claims description 4
• 102100037116 Transcription elongation factor 1 homolog Human genes 0.000 claims description 4
• 101150004676 VGF gene Proteins 0.000 claims description 4
• 102100038170 Vesicular inhibitory amino acid transporter Human genes 0.000 claims description 4
• 108091008324 binding proteins Proteins 0.000 claims description 4
• 230000001713 cholinergic effect Effects 0.000 claims description 4
• 102000004419 dihydrofolate reductase Human genes 0.000 claims description 4
• 230000003371 gabaergic effect Effects 0.000 claims description 4
• 239000003862 glucocorticoid Substances 0.000 claims description 4
• 210000001153 interneuron Anatomy 0.000 claims description 4
• 238000007913 intrathecal administration Methods 0.000 claims description 4
• 210000004698 lymphocyte Anatomy 0.000 claims description 4
• 210000000274 microglia Anatomy 0.000 claims description 4
• 108091008695 photoreceptors Proteins 0.000 claims description 4
• 108010079094 short-wavelength opsin Proteins 0.000 claims description 4
• 108700026220 vif Genes Proteins 0.000 claims description 4
• 101800003906 Substance P Proteins 0.000 claims description 3
• 238000007914 intraventricular administration Methods 0.000 claims description 3
• 102100032617 Pulmonary surfactant-associated protein B Human genes 0.000 claims 3
• 102000004330 Rhodopsin Human genes 0.000 claims 3
• 102000005881 S100 Calcium Binding Protein A6 Human genes 0.000 claims 3
• 239000000203 mixture Substances 0.000 abstract description 35
• 241000702421 Dependoparvovirus Species 0.000 abstract description 12
• 238000001415 gene therapy Methods 0.000 abstract description 12
• 230000004075 alteration Effects 0.000 abstract description 4
• 101710081079 Minor spike protein H Proteins 0.000 description 76
• 125000003275 alpha amino acid group Chemical group 0.000 description 75
• 101710132601 Capsid protein Proteins 0.000 description 74
• 101710197658 Capsid protein VP1 Proteins 0.000 description 74
• 101710118046 RNA-directed RNA polymerase Proteins 0.000 description 74
• 101710108545 Viral protein 1 Proteins 0.000 description 74
• 206010028980 Neoplasm Diseases 0.000 description 66
• 230000002163 immunogen Effects 0.000 description 53
• 201000010099 disease Diseases 0.000 description 40
• 201000011510 cancer Diseases 0.000 description 35
• 108091007433 antigens Proteins 0.000 description 32
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 31
• 239000000427 antigen Substances 0.000 description 31
• 102000036639 antigens Human genes 0.000 description 31
• 238000004806 packaging method and process Methods 0.000 description 27
• 230000000694 effects Effects 0.000 description 25
• 238000013518 transcription Methods 0.000 description 23
• 230000035897 transcription Effects 0.000 description 23
• 125000003729 nucleotide group Chemical group 0.000 description 22
• 230000002401 inhibitory effect Effects 0.000 description 21
• 239000002773 nucleotide Substances 0.000 description 21
• 230000010076 replication Effects 0.000 description 20
• 230000028993 immune response Effects 0.000 description 17
• 230000004807 localization Effects 0.000 description 17
• 239000012634 fragment Substances 0.000 description 16
• 238000002347 injection Methods 0.000 description 16
• 239000007924 injection Substances 0.000 description 16
• 239000000047 product Substances 0.000 description 16
• 239000005090 green fluorescent protein Substances 0.000 description 15
• 238000001727 in vivo Methods 0.000 description 15
• 108020004414 DNA Proteins 0.000 description 14
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 13
• 108091028043 Nucleic acid sequence Proteins 0.000 description 13
• 210000004899 c-terminal region Anatomy 0.000 description 13
• 230000001976 improved effect Effects 0.000 description 13
• 230000001965 increasing effect Effects 0.000 description 13
• 239000007788 liquid Substances 0.000 description 13
• 208000024891 symptom Diseases 0.000 description 13
• 208000032003 Glycogen storage disease due to glucose-6-phosphatase deficiency Diseases 0.000 description 12
• 206010018464 Glycogen storage disease type I Diseases 0.000 description 12
• 102100039939 Growth/differentiation factor 8 Human genes 0.000 description 12
• 108010056852 Myostatin Proteins 0.000 description 12
• 241000700159 Rattus Species 0.000 description 12
• 201000004541 glycogen storage disease I Diseases 0.000 description 12
• 239000007787 solid Substances 0.000 description 12
• 230000014616 translation Effects 0.000 description 12
• 238000007792 addition Methods 0.000 description 11
• 230000008901 benefit Effects 0.000 description 11
• 230000027455 binding Effects 0.000 description 11
• 210000003205 muscle Anatomy 0.000 description 11
• 210000001577 neostriatum Anatomy 0.000 description 11
• 230000001537 neural effect Effects 0.000 description 11
• 210000004940 nucleus Anatomy 0.000 description 11
• 238000013519 translation Methods 0.000 description 11
• 102000004127 Cytokines Human genes 0.000 description 10
• 108090000695 Cytokines Proteins 0.000 description 10
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
• 101001040800 Homo sapiens Integral membrane protein GPR180 Proteins 0.000 description 10
• 102100021244 Integral membrane protein GPR180 Human genes 0.000 description 10
• 230000008045 co-localization Effects 0.000 description 10
• 238000001990 intravenous administration Methods 0.000 description 10
• 238000004519 manufacturing process Methods 0.000 description 10
• 210000002027 skeletal muscle Anatomy 0.000 description 10
• 238000010361 transduction Methods 0.000 description 10
• 230000026683 transduction Effects 0.000 description 10
• 238000011282 treatment Methods 0.000 description 10
• 108020004705 Codon Proteins 0.000 description 9
• 241001465754 Metazoa Species 0.000 description 9
• 108020004459 Small interfering RNA Proteins 0.000 description 9
• 239000000443 aerosol Substances 0.000 description 9
• 229940079322 interferon Drugs 0.000 description 9
• 230000001681 protective effect Effects 0.000 description 9
• 238000011002 quantification Methods 0.000 description 9
• 102000005962 receptors Human genes 0.000 description 9
• 108020003175 receptors Proteins 0.000 description 9
• 238000012546 transfer Methods 0.000 description 9
• 108010025020 Nerve Growth Factor Proteins 0.000 description 8
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 8
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 8
• 230000003247 decreasing effect Effects 0.000 description 8
• 238000009472 formulation Methods 0.000 description 8
• 210000000056 organ Anatomy 0.000 description 8
• 108010059929 phospholamban Proteins 0.000 description 8
• 210000000130 stem cell Anatomy 0.000 description 8
• 230000000699 topical effect Effects 0.000 description 8
• 230000010415 tropism Effects 0.000 description 8
• 101100524324 Adeno-associated virus 2 (isolate Srivastava/1982) Rep78 gene Proteins 0.000 description 7
• 101000805768 Banna virus (strain Indonesia/JKT-6423/1980) mRNA (guanine-N(7))-methyltransferase Proteins 0.000 description 7
• 108090000994 Catalytic RNA Proteins 0.000 description 7
• 102000053642 Catalytic RNA Human genes 0.000 description 7
• 101000686790 Chaetoceros protobacilladnavirus 2 Replication-associated protein Proteins 0.000 description 7
• 101000864475 Chlamydia phage 1 Internal scaffolding protein VP3 Proteins 0.000 description 7
• 101000803553 Eumenes pomiformis Venom peptide 3 Proteins 0.000 description 7
• 101000583961 Halorubrum pleomorphic virus 1 Matrix protein Proteins 0.000 description 7
• 241000725303 Human immunodeficiency virus Species 0.000 description 7
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 7
• 208000008955 Mucolipidoses Diseases 0.000 description 7
• 102000007072 Nerve Growth Factors Human genes 0.000 description 7
• 230000000692 anti-sense effect Effects 0.000 description 7
• 230000001413 cellular effect Effects 0.000 description 7
• 239000003795 chemical substances by application Substances 0.000 description 7
• 230000007812 deficiency Effects 0.000 description 7
• 230000000977 initiatory effect Effects 0.000 description 7
• 239000003550 marker Substances 0.000 description 7
• 239000003900 neurotrophic factor Substances 0.000 description 7
• 102000005681 phospholamban Human genes 0.000 description 7
• 230000002265 prevention Effects 0.000 description 7
• 108091092562 ribozyme Proteins 0.000 description 7
• 239000000243 solution Substances 0.000 description 7
• 241000894007 species Species 0.000 description 7
• 101100524317 Adeno-associated virus 2 (isolate Srivastava/1982) Rep40 gene Proteins 0.000 description 6
• 101100524319 Adeno-associated virus 2 (isolate Srivastava/1982) Rep52 gene Proteins 0.000 description 6
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
• 230000004568 DNA-binding Effects 0.000 description 6
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 6
• 241000699666 Mus <mouse, genus> Species 0.000 description 6
• 108091027967 Small hairpin RNA Proteins 0.000 description 6
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
• 239000002870 angiogenesis inducing agent Substances 0.000 description 6
• 238000010171 animal model Methods 0.000 description 6
• 230000003110 anti-inflammatory effect Effects 0.000 description 6
• 210000004556 brain Anatomy 0.000 description 6
• 229910052799 carbon Inorganic materials 0.000 description 6
• 239000003814 drug Substances 0.000 description 6
• 210000002889 endothelial cell Anatomy 0.000 description 6
• 210000003414 extremity Anatomy 0.000 description 6
• BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 6
• 230000036039 immunity Effects 0.000 description 6
• 238000002372 labelling Methods 0.000 description 6
• 210000004962 mammalian cell Anatomy 0.000 description 6
• 239000000463 material Substances 0.000 description 6
• 108010043671 prostatic acid phosphatase Proteins 0.000 description 6
• ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 6
• 229960002930 sirolimus Drugs 0.000 description 6
• QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 6
• 239000004055 small Interfering RNA Substances 0.000 description 6
• 210000003863 superior colliculi Anatomy 0.000 description 6
• 239000000725 suspension Substances 0.000 description 6
• 230000008685 targeting Effects 0.000 description 6
• 238000011144 upstream manufacturing Methods 0.000 description 6
• 101100524321 Adeno-associated virus 2 (isolate Srivastava/1982) Rep68 gene Proteins 0.000 description 5
• 102400000068 Angiostatin Human genes 0.000 description 5
• 108010079709 Angiostatins Proteins 0.000 description 5
• 241000283707 Capra Species 0.000 description 5
• 102100031162 Collagen alpha-1(XVIII) chain Human genes 0.000 description 5
• 206010010904 Convulsion Diseases 0.000 description 5
• 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 description 5
• 108010079505 Endostatins Proteins 0.000 description 5
• 102000004190 Enzymes Human genes 0.000 description 5
• 108090000790 Enzymes Proteins 0.000 description 5
• 108700026244 Open Reading Frames Proteins 0.000 description 5
• 102100023085 Serine/threonine-protein kinase mTOR Human genes 0.000 description 5
• 241000713311 Simian immunodeficiency virus Species 0.000 description 5
• 101710172711 Structural protein Proteins 0.000 description 5
• FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 description 5
• 230000001580 bacterial effect Effects 0.000 description 5
• 230000004071 biological effect Effects 0.000 description 5
• 230000015572 biosynthetic process Effects 0.000 description 5
• 230000007547 defect Effects 0.000 description 5
• 238000005516 engineering process Methods 0.000 description 5
• 229940088598 enzyme Drugs 0.000 description 5
• 210000002919 epithelial cell Anatomy 0.000 description 5
• 108091006104 gene-regulatory proteins Proteins 0.000 description 5
• 238000003018 immunoassay Methods 0.000 description 5
• 210000004072 lung Anatomy 0.000 description 5
• 230000002132 lysosomal effect Effects 0.000 description 5
• 230000001404 mediated effect Effects 0.000 description 5
• VKHAHZOOUSRJNA-GCNJZUOMSA-N mifepristone Chemical compound C1([C@@H]2C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]3CC[C@@]([C@]3(C2)C)(O)C#CC)=CC=C(N(C)C)C=C1 VKHAHZOOUSRJNA-GCNJZUOMSA-N 0.000 description 5
• 210000004165 myocardium Anatomy 0.000 description 5
• 238000005457 optimization Methods 0.000 description 5
• 230000010412 perfusion Effects 0.000 description 5
• 230000002829 reductive effect Effects 0.000 description 5
• 230000035945 sensitivity Effects 0.000 description 5
• 210000003491 skin Anatomy 0.000 description 5
• 210000002460 smooth muscle Anatomy 0.000 description 5
• 239000000758 substrate Substances 0.000 description 5
• 230000002103 transcriptional effect Effects 0.000 description 5
• 241000712461 unidentified influenza virus Species 0.000 description 5
• 229960005486 vaccine Drugs 0.000 description 5
• 239000003981 vehicle Substances 0.000 description 5
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 4
• 241000271566 Aves Species 0.000 description 4
• 241000283073 Equus caballus Species 0.000 description 4
• 102000003951 Erythropoietin Human genes 0.000 description 4
• 108090000394 Erythropoietin Proteins 0.000 description 4
• 101710154606 Hemagglutinin Proteins 0.000 description 4
• 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 4
• 241000282560 Macaca mulatta Species 0.000 description 4
• 208000019022 Mood disease Diseases 0.000 description 4
• 206010056886 Mucopolysaccharidosis I Diseases 0.000 description 4
• 206010028095 Mucopolysaccharidosis IV Diseases 0.000 description 4
• 101710093908 Outer capsid protein VP4 Proteins 0.000 description 4
• 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 4
• 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 4
• 102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 description 4
• 108010064071 Phosphorylase Kinase Proteins 0.000 description 4
• 102000014750 Phosphorylase Kinase Human genes 0.000 description 4
• 101710176177 Protein A56 Proteins 0.000 description 4
• 108700008625 Reporter Genes Proteins 0.000 description 4
• 239000002253 acid Substances 0.000 description 4
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 4
• 210000001185 bone marrow Anatomy 0.000 description 4
• 239000000969 carrier Substances 0.000 description 4
• 239000002771 cell marker Substances 0.000 description 4
• 239000003153 chemical reaction reagent Substances 0.000 description 4
• 210000000349 chromosome Anatomy 0.000 description 4
• 230000002950 deficient Effects 0.000 description 4
• 229940079593 drug Drugs 0.000 description 4
• 229940105423 erythropoietin Drugs 0.000 description 4
• 238000002376 fluorescence recovery after photobleaching Methods 0.000 description 4
• 210000001035 gastrointestinal tract Anatomy 0.000 description 4
• 238000001476 gene delivery Methods 0.000 description 4
• 102000034356 gene-regulatory proteins Human genes 0.000 description 4
• 239000008187 granular material Substances 0.000 description 4
• 239000000185 hemagglutinin Substances 0.000 description 4
• 208000002672 hepatitis B Diseases 0.000 description 4
• 230000002458 infectious effect Effects 0.000 description 4
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
• 238000001361 intraarterial administration Methods 0.000 description 4
• 210000003734 kidney Anatomy 0.000 description 4
• 239000003446 ligand Substances 0.000 description 4
• 239000011159 matrix material Substances 0.000 description 4
• 108020004999 messenger RNA Proteins 0.000 description 4
• 201000006938 muscular dystrophy Diseases 0.000 description 4
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 4
• 239000000843 powder Substances 0.000 description 4
• 210000003314 quadriceps muscle Anatomy 0.000 description 4
• 230000009467 reduction Effects 0.000 description 4
• 238000011160 research Methods 0.000 description 4
• 210000001525 retina Anatomy 0.000 description 4
• 230000002207 retinal effect Effects 0.000 description 4
• 150000003384 small molecules Chemical class 0.000 description 4
• 239000011780 sodium chloride Substances 0.000 description 4
• 210000004989 spleen cell Anatomy 0.000 description 4
• 239000000126 substance Substances 0.000 description 4
• 239000003826 tablet Substances 0.000 description 4
• 230000002463 transducing effect Effects 0.000 description 4
• OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 3
• 102100022548 Beta-hexosaminidase subunit alpha Human genes 0.000 description 3
• 241000283690 Bos taurus Species 0.000 description 3
• 208000003174 Brain Neoplasms Diseases 0.000 description 3
• 201000003883 Cystic fibrosis Diseases 0.000 description 3
• 206010012689 Diabetic retinopathy Diseases 0.000 description 3
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
• UPEZCKBFRMILAV-JNEQICEOSA-N Ecdysone Natural products O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@H]([C@@H](O)CCC(O)(C)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2 UPEZCKBFRMILAV-JNEQICEOSA-N 0.000 description 3
• 108700024394 Exon Proteins 0.000 description 3
• 108010014612 Follistatin Proteins 0.000 description 3
• 102000016970 Follistatin Human genes 0.000 description 3
• 208000010412 Glaucoma Diseases 0.000 description 3
• 102000034615 Glial cell line-derived neurotrophic factor Human genes 0.000 description 3
• 108091010837 Glial cell line-derived neurotrophic factor Proteins 0.000 description 3
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
• 108010017544 Glucosylceramidase Proteins 0.000 description 3
• 102000004547 Glucosylceramidase Human genes 0.000 description 3
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 3
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 3
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 3
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 3
• 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 3
• 208000008839 Kidney Neoplasms Diseases 0.000 description 3
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 3
• 108010001831 LDL receptors Proteins 0.000 description 3
• 206010023927 Lassa fever Diseases 0.000 description 3
• 102100024640 Low-density lipoprotein receptor Human genes 0.000 description 3
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
• 208000027933 Mannosidase Deficiency disease Diseases 0.000 description 3
• 206010048723 Multiple-drug resistance Diseases 0.000 description 3
• 241000699660 Mus musculus Species 0.000 description 3
• 108091005461 Nucleic proteins Proteins 0.000 description 3
• 241000283973 Oryctolagus cuniculus Species 0.000 description 3
• 229910019142 PO4 Inorganic materials 0.000 description 3
• 208000018737 Parkinson disease Diseases 0.000 description 3
• 241000286209 Phasianidae Species 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• 101710150114 Protein rep Proteins 0.000 description 3
• 206010038389 Renal cancer Diseases 0.000 description 3
• 101710152114 Replication protein Proteins 0.000 description 3
• 208000007014 Retinitis pigmentosa Diseases 0.000 description 3
• 102000013275 Somatomedins Human genes 0.000 description 3
• 108010061312 Sphingomyelin Phosphodiesterase Proteins 0.000 description 3
• 102000011971 Sphingomyelin Phosphodiesterase Human genes 0.000 description 3
• 108010027179 Tacrolimus Binding Proteins Proteins 0.000 description 3
• 102000018679 Tacrolimus Binding Proteins Human genes 0.000 description 3
• 206010054094 Tumour necrosis Diseases 0.000 description 3
• 108010075653 Utrophin Proteins 0.000 description 3
• 102000011856 Utrophin Human genes 0.000 description 3
• 239000012190 activator Substances 0.000 description 3
• UPEZCKBFRMILAV-UHFFFAOYSA-N alpha-Ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C(O)CCC(C)(C)O)C)CCC33O)C)C3=CC(=O)C21 UPEZCKBFRMILAV-UHFFFAOYSA-N 0.000 description 3
• 238000004458 analytical method Methods 0.000 description 3
• 230000033115 angiogenesis Effects 0.000 description 3
• 230000001772 anti-angiogenic effect Effects 0.000 description 3
• 230000009286 beneficial effect Effects 0.000 description 3
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
• 210000004369 blood Anatomy 0.000 description 3
• 239000008280 blood Substances 0.000 description 3
• 230000000747 cardiac effect Effects 0.000 description 3
• 210000000170 cell membrane Anatomy 0.000 description 3
• 150000001875 compounds Chemical class 0.000 description 3
• 210000004443 dendritic cell Anatomy 0.000 description 3
• 239000008121 dextrose Substances 0.000 description 3
• UPEZCKBFRMILAV-JMZLNJERSA-N ecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@H]([C@H](O)CCC(C)(C)O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 UPEZCKBFRMILAV-JMZLNJERSA-N 0.000 description 3
• 108010057988 ecdysone receptor Proteins 0.000 description 3
• 239000000839 emulsion Substances 0.000 description 3
• 206010015037 epilepsy Diseases 0.000 description 3
• 229940011871 estrogen Drugs 0.000 description 3
• 239000000262 estrogen Substances 0.000 description 3
• 230000004927 fusion Effects 0.000 description 3
• 229960003692 gamma aminobutyric acid Drugs 0.000 description 3
• 208000007345 glycogen storage disease Diseases 0.000 description 3
• 230000012010 growth Effects 0.000 description 3
• 239000003102 growth factor Substances 0.000 description 3
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 3
• 208000006454 hepatitis Diseases 0.000 description 3
• 231100000283 hepatitis Toxicity 0.000 description 3
• 210000003494 hepatocyte Anatomy 0.000 description 3
• 210000004408 hybridoma Anatomy 0.000 description 3
• 210000003552 inferior colliculi Anatomy 0.000 description 3
• 239000003112 inhibitor Substances 0.000 description 3
• 238000007912 intraperitoneal administration Methods 0.000 description 3
• 201000010982 kidney cancer Diseases 0.000 description 3
• 230000000670 limiting effect Effects 0.000 description 3
• 208000002780 macular degeneration Diseases 0.000 description 3
• 201000001441 melanoma Diseases 0.000 description 3
• 239000002207 metabolite Substances 0.000 description 3
• 229960003248 mifepristone Drugs 0.000 description 3
• 208000005340 mucopolysaccharidosis III Diseases 0.000 description 3
• 210000000663 muscle cell Anatomy 0.000 description 3
• 210000001178 neural stem cell Anatomy 0.000 description 3
• 208000015122 neurodegenerative disease Diseases 0.000 description 3
• 229940037201 oris Drugs 0.000 description 3
• 230000002093 peripheral effect Effects 0.000 description 3
• 239000010452 phosphate Substances 0.000 description 3
• 230000008488 polyadenylation Effects 0.000 description 3
• 229920001223 polyethylene glycol Polymers 0.000 description 3
• 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 3
• 230000002441 reversible effect Effects 0.000 description 3
• 238000012216 screening Methods 0.000 description 3
• NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 3
• 208000002320 spinal muscular atrophy Diseases 0.000 description 3
• 210000000952 spleen Anatomy 0.000 description 3
• 239000007858 starting material Substances 0.000 description 3
• 208000011580 syndromic disease Diseases 0.000 description 3
• 230000002123 temporal effect Effects 0.000 description 3
• 238000002560 therapeutic procedure Methods 0.000 description 3
• 238000011830 transgenic mouse model Methods 0.000 description 3
• 210000004881 tumor cell Anatomy 0.000 description 3
• 230000029812 viral genome replication Effects 0.000 description 3
• 210000002845 virion Anatomy 0.000 description 3
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
• SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 2
• 108010046716 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) Proteins 0.000 description 2
• 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 2
• IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
• 108010059616 Activins Proteins 0.000 description 2
• 102000055025 Adenosine deaminases Human genes 0.000 description 2
• 208000017194 Affective disease Diseases 0.000 description 2
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
• 208000024827 Alzheimer disease Diseases 0.000 description 2
• 208000031277 Amaurotic familial idiocy Diseases 0.000 description 2
• 241000272517 Anseriformes Species 0.000 description 2
• 102100022440 Battenin Human genes 0.000 description 2
• 201000006935 Becker muscular dystrophy Diseases 0.000 description 2
• 241000701922 Bovine parvovirus Species 0.000 description 2
• 206010006187 Breast cancer Diseases 0.000 description 2
• 208000026310 Breast neoplasm Diseases 0.000 description 2
• 241000701931 Canine parvovirus Species 0.000 description 2
• 241000282465 Canis Species 0.000 description 2
• 102100026548 Caspase-8 Human genes 0.000 description 2
• 108090000538 Caspase-8 Proteins 0.000 description 2
• 206010008342 Cervix carcinoma Diseases 0.000 description 2
• 206010009944 Colon cancer Diseases 0.000 description 2
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 2
• 108091000069 Cystinyl Aminopeptidase Proteins 0.000 description 2
• 102000053602 DNA Human genes 0.000 description 2
• 241000238557 Decapoda Species 0.000 description 2
• 108010053187 Diphtheria Toxin Proteins 0.000 description 2
• 102000016607 Diphtheria Toxin Human genes 0.000 description 2
• 241000588724 Escherichia coli Species 0.000 description 2
• 208000000461 Esophageal Neoplasms Diseases 0.000 description 2
• 208000024720 Fabry Disease Diseases 0.000 description 2
• 206010016654 Fibrosis Diseases 0.000 description 2
• 102000006575 G-Protein-Coupled Receptor Kinases Human genes 0.000 description 2
• 108010008959 G-Protein-Coupled Receptor Kinases Proteins 0.000 description 2
• 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 description 2
• 208000001905 GM2 Gangliosidoses Diseases 0.000 description 2
• 201000008905 GM2 gangliosidosis Diseases 0.000 description 2
• 208000017462 Galactosialidosis Diseases 0.000 description 2
• 208000015872 Gaucher disease Diseases 0.000 description 2
• 102400000322 Glucagon-like peptide 1 Human genes 0.000 description 2
• DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 2
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
• 208000032007 Glycogen storage disease due to acid maltase deficiency Diseases 0.000 description 2
• 206010053185 Glycogen storage disease type II Diseases 0.000 description 2
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 2
• 108010051696 Growth Hormone Proteins 0.000 description 2
• 229920002971 Heparan sulfate Polymers 0.000 description 2
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
• 208000005176 Hepatitis C Diseases 0.000 description 2
• 241000238631 Hexapoda Species 0.000 description 2
• 208000017604 Hodgkin disease Diseases 0.000 description 2
• 208000021519 Hodgkin lymphoma Diseases 0.000 description 2
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 2
• 101001045440 Homo sapiens Beta-hexosaminidase subunit alpha Proteins 0.000 description 2
• 101000685712 Homo sapiens Protein S100-A1 Proteins 0.000 description 2
• 244000309467 Human Coronavirus Species 0.000 description 2
• 241000702617 Human parvovirus B19 Species 0.000 description 2
• 208000023105 Huntington disease Diseases 0.000 description 2
• 108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 2
• 102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 2
• 206010021143 Hypoxia Diseases 0.000 description 2
• 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 2
• 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 2
• 208000026350 Inborn Genetic disease Diseases 0.000 description 2
• 206010061218 Inflammation Diseases 0.000 description 2
• 102100026818 Inhibin beta E chain Human genes 0.000 description 2
• 102000004877 Insulin Human genes 0.000 description 2
• 108090001061 Insulin Proteins 0.000 description 2
• 108010002350 Interleukin-2 Proteins 0.000 description 2
• 102000000588 Interleukin-2 Human genes 0.000 description 2
• 108060005987 Kallikrein Proteins 0.000 description 2
• 102000001399 Kallikrein Human genes 0.000 description 2
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
• 240000007472 Leucaena leucocephala Species 0.000 description 2
• 235000010643 Leucaena leucocephala Nutrition 0.000 description 2
• 102100020872 Leucyl-cystinyl aminopeptidase Human genes 0.000 description 2
• 108060001084 Luciferase Proteins 0.000 description 2
• 239000005089 Luciferase Substances 0.000 description 2
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
• 206010025323 Lymphomas Diseases 0.000 description 2
• 102000004083 Lymphotoxin-alpha Human genes 0.000 description 2
• 108090000542 Lymphotoxin-alpha Proteins 0.000 description 2
• 239000004472 Lysine Substances 0.000 description 2
• 102100033448 Lysosomal alpha-glucosidase Human genes 0.000 description 2
• 208000015439 Lysosomal storage disease Diseases 0.000 description 2
• 241000124008 Mammalia Species 0.000 description 2
• 108010027796 Membrane Fusion Proteins Proteins 0.000 description 2
• 102000018897 Membrane Fusion Proteins Human genes 0.000 description 2
• 206010027476 Metastases Diseases 0.000 description 2
• 206010072927 Mucolipidosis type I Diseases 0.000 description 2
• 206010072928 Mucolipidosis type II Diseases 0.000 description 2
• 241000699670 Mus sp. Species 0.000 description 2
• 102000003729 Neprilysin Human genes 0.000 description 2
• 108090000028 Neprilysin Proteins 0.000 description 2
• 208000002537 Neuronal Ceroid-Lipofuscinoses Diseases 0.000 description 2
• 208000014060 Niemann-Pick disease Diseases 0.000 description 2
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 2
• 206010030155 Oesophageal carcinoma Diseases 0.000 description 2
• 206010033128 Ovarian cancer Diseases 0.000 description 2
• 206010061535 Ovarian neoplasm Diseases 0.000 description 2
• 108091007960 PI3Ks Proteins 0.000 description 2
• 102000001675 Parvalbumin Human genes 0.000 description 2
• 108060005874 Parvalbumin Proteins 0.000 description 2
• 241001494479 Pecora Species 0.000 description 2
• 102100027913 Peptidyl-prolyl cis-trans isomerase FKBP1A Human genes 0.000 description 2
• 108010073135 Phosphorylases Proteins 0.000 description 2
• 102000009097 Phosphorylases Human genes 0.000 description 2
• 208000007913 Pituitary Neoplasms Diseases 0.000 description 2
• 239000002202 Polyethylene glycol Substances 0.000 description 2
• 241000288906 Primates Species 0.000 description 2
• 206010060862 Prostate cancer Diseases 0.000 description 2
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
• 102100023097 Protein S100-A1 Human genes 0.000 description 2
• 102100032421 Protein S100-A6 Human genes 0.000 description 2
• 241000411545 Punargentus Species 0.000 description 2
• 102000014128 RANK Ligand Human genes 0.000 description 2
• 108010025832 RANK Ligand Proteins 0.000 description 2
• 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 2
• 201000007737 Retinal degeneration Diseases 0.000 description 2
• 102100031774 Ribitol 5-phosphate transferase FKRP Human genes 0.000 description 2
• 101710087595 Ribitol 5-phosphate transferase FKRP Proteins 0.000 description 2
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
• 108010083379 Sarcoglycans Proteins 0.000 description 2
• 102000006308 Sarcoglycans Human genes 0.000 description 2
• 206010039491 Sarcoma Diseases 0.000 description 2
• 102000011265 Sarcospan Human genes 0.000 description 2
• 108050001531 Sarcospan Proteins 0.000 description 2
• 241000270295 Serpentes Species 0.000 description 2
• 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 2
• 208000027520 Somatoform disease Diseases 0.000 description 2
• 102000005157 Somatostatin Human genes 0.000 description 2
• 108010056088 Somatostatin Proteins 0.000 description 2
• 102100038803 Somatotropin Human genes 0.000 description 2
• 229930006000 Sucrose Natural products 0.000 description 2
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
• 102000005262 Sulfatase Human genes 0.000 description 2
• 102000019197 Superoxide Dismutase Human genes 0.000 description 2
• 102000008221 Superoxide Dismutase-1 Human genes 0.000 description 2
• 108010021188 Superoxide Dismutase-1 Proteins 0.000 description 2
• 108010012715 Superoxide dismutase Proteins 0.000 description 2
• 102220564325 TIR domain-containing adapter molecule 2_S16E_mutation Human genes 0.000 description 2
• 108010006877 Tacrolimus Binding Protein 1A Proteins 0.000 description 2
• 208000022292 Tay-Sachs disease Diseases 0.000 description 2
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
• 102000003425 Tyrosinase Human genes 0.000 description 2
• 108060008724 Tyrosinase Proteins 0.000 description 2
• 108091026823 U7 small nuclear RNA Proteins 0.000 description 2
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
• 208000002495 Uterine Neoplasms Diseases 0.000 description 2
• 206010046851 Uveitis Diseases 0.000 description 2
• 206010046865 Vaccinia virus infection Diseases 0.000 description 2
• 101001001642 Xenopus laevis Serine/threonine-protein kinase pim-3 Proteins 0.000 description 2
• 230000002159 abnormal effect Effects 0.000 description 2
• IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 2
• 230000021736 acetylation Effects 0.000 description 2
• 238000006640 acetylation reaction Methods 0.000 description 2
• 230000004913 activation Effects 0.000 description 2
• 239000000488 activin Substances 0.000 description 2
• 102000030621 adenylate cyclase Human genes 0.000 description 2
• 108060000200 adenylate cyclase Proteins 0.000 description 2
• 206010064930 age-related macular degeneration Diseases 0.000 description 2
• 230000009435 amidation Effects 0.000 description 2
• 238000007112 amidation reaction Methods 0.000 description 2
• 239000012491 analyte Substances 0.000 description 2
• 208000007502 anemia Diseases 0.000 description 2
• 210000002159 anterior chamber Anatomy 0.000 description 2
• 230000002424 anti-apoptotic effect Effects 0.000 description 2
• 239000003963 antioxidant agent Substances 0.000 description 2
• 235000006708 antioxidants Nutrition 0.000 description 2
• 239000000074 antisense oligonucleotide Substances 0.000 description 2
• 238000012230 antisense oligonucleotides Methods 0.000 description 2
• 238000013459 approach Methods 0.000 description 2
• 239000008365 aqueous carrier Substances 0.000 description 2
• 239000007864 aqueous solution Substances 0.000 description 2
• 206010003246 arthritis Diseases 0.000 description 2
• 239000011230 binding agent Substances 0.000 description 2
• 230000033228 biological regulation Effects 0.000 description 2
• 210000002449 bone cell Anatomy 0.000 description 2
• 210000004958 brain cell Anatomy 0.000 description 2
• 239000000872 buffer Substances 0.000 description 2
• 238000004364 calculation method Methods 0.000 description 2
• 239000002775 capsule Substances 0.000 description 2
• 210000004413 cardiac myocyte Anatomy 0.000 description 2
• 230000003197 catalytic effect Effects 0.000 description 2
• 230000010261 cell growth Effects 0.000 description 2
• 230000002490 cerebral effect Effects 0.000 description 2
• 206010008118 cerebral infarction Diseases 0.000 description 2
• 210000004720 cerebrum Anatomy 0.000 description 2
• 201000010881 cervical cancer Diseases 0.000 description 2
• 230000008859 change Effects 0.000 description 2
• 235000013330 chicken meat Nutrition 0.000 description 2
• 230000000295 complement effect Effects 0.000 description 2
• 230000009918 complex formation Effects 0.000 description 2
• 210000004087 cornea Anatomy 0.000 description 2
• 210000001653 corpus striatum Anatomy 0.000 description 2
• 210000004748 cultured cell Anatomy 0.000 description 2
• 230000006378 damage Effects 0.000 description 2
• 230000007850 degeneration Effects 0.000 description 2
• 238000001514 detection method Methods 0.000 description 2
• 238000011161 development Methods 0.000 description 2
• 238000010586 diagram Methods 0.000 description 2
• 208000037765 diseases and disorders Diseases 0.000 description 2
• 239000002552 dosage form Substances 0.000 description 2
• 229960003722 doxycycline Drugs 0.000 description 2
• 239000003995 emulsifying agent Substances 0.000 description 2
• 238000007824 enzymatic assay Methods 0.000 description 2
• 210000000981 epithelium Anatomy 0.000 description 2
• 108700020302 erbB-2 Genes Proteins 0.000 description 2
• 201000004101 esophageal cancer Diseases 0.000 description 2
• 102000015694 estrogen receptors Human genes 0.000 description 2
• 108010038795 estrogen receptors Proteins 0.000 description 2
• 210000003527 eukaryotic cell Anatomy 0.000 description 2
• 210000002950 fibroblast Anatomy 0.000 description 2
• 108020001507 fusion proteins Proteins 0.000 description 2
• 102000037865 fusion proteins Human genes 0.000 description 2
• 238000003197 gene knockdown Methods 0.000 description 2
• 238000012239 gene modification Methods 0.000 description 2
• 208000016361 genetic disease Diseases 0.000 description 2
• 230000002068 genetic effect Effects 0.000 description 2
• 210000004602 germ cell Anatomy 0.000 description 2
• 230000002518 glial effect Effects 0.000 description 2
• 208000005017 glioblastoma Diseases 0.000 description 2
• 101150117187 glmS gene Proteins 0.000 description 2
• 210000001905 globus pallidus Anatomy 0.000 description 2
• XHMJOUIAFHJHBW-VFUOTHLCSA-N glucosamine 6-phosphate Chemical compound N[C@H]1[C@H](O)O[C@H](COP(O)(O)=O)[C@H](O)[C@@H]1O XHMJOUIAFHJHBW-VFUOTHLCSA-N 0.000 description 2
• 229930195712 glutamate Natural products 0.000 description 2
• 201000004502 glycogen storage disease II Diseases 0.000 description 2
• 201000008977 glycoproteinosis Diseases 0.000 description 2
• 201000010536 head and neck cancer Diseases 0.000 description 2
• 208000014829 head and neck neoplasm Diseases 0.000 description 2
• 229960002897 heparin Drugs 0.000 description 2
• 210000001320 hippocampus Anatomy 0.000 description 2
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
• 229940088597 hormone Drugs 0.000 description 2
• 239000005556 hormone Substances 0.000 description 2
• 230000002519 immonomodulatory effect Effects 0.000 description 2
• 230000009851 immunogenic response Effects 0.000 description 2
• 230000005847 immunogenicity Effects 0.000 description 2
• 230000006872 improvement Effects 0.000 description 2
• 239000000411 inducer Substances 0.000 description 2
• 230000004054 inflammatory process Effects 0.000 description 2
• 238000001802 infusion Methods 0.000 description 2
• 239000004615 ingredient Substances 0.000 description 2
• 229940125396 insulin Drugs 0.000 description 2
• 230000010354 integration Effects 0.000 description 2
• 230000002452 interceptive effect Effects 0.000 description 2
• 238000007918 intramuscular administration Methods 0.000 description 2
• 210000004153 islets of langerhan Anatomy 0.000 description 2
• 208000017476 juvenile neuronal ceroid lipofuscinosis Diseases 0.000 description 2
• 210000002510 keratinocyte Anatomy 0.000 description 2
• 210000005246 left atrium Anatomy 0.000 description 2
• 210000005240 left ventricle Anatomy 0.000 description 2
• 208000032839 leukemia Diseases 0.000 description 2
• 108020001756 ligand binding domains Proteins 0.000 description 2
• 239000012669 liquid formulation Substances 0.000 description 2
• 201000007270 liver cancer Diseases 0.000 description 2
• 208000014018 liver neoplasm Diseases 0.000 description 2
• 239000007937 lozenge Substances 0.000 description 2
• 201000005202 lung cancer Diseases 0.000 description 2
• 210000005265 lung cell Anatomy 0.000 description 2
• 208000020816 lung neoplasm Diseases 0.000 description 2
• 210000001165 lymph node Anatomy 0.000 description 2
• 230000007246 mechanism Effects 0.000 description 2
• 230000009401 metastasis Effects 0.000 description 2
• 230000001394 metastastic effect Effects 0.000 description 2
• 206010061289 metastatic neoplasm Diseases 0.000 description 2
• 230000011987 methylation Effects 0.000 description 2
• 238000007069 methylation reaction Methods 0.000 description 2
• 230000000813 microbial effect Effects 0.000 description 2
• 230000003228 microsomal effect Effects 0.000 description 2
• 238000010369 molecular cloning Methods 0.000 description 2
• 230000000921 morphogenic effect Effects 0.000 description 2
• 210000002161 motor neuron Anatomy 0.000 description 2
• 238000000465 moulding Methods 0.000 description 2
• 208000020460 mucolipidosis II alpha/beta Diseases 0.000 description 2
• 208000020468 mucolipidosis III alpha/beta Diseases 0.000 description 2
• 208000022018 mucopolysaccharidosis type 2 Diseases 0.000 description 2
• 208000025919 mucopolysaccharidosis type 7 Diseases 0.000 description 2
• 201000006417 multiple sclerosis Diseases 0.000 description 2
• 239000002105 nanoparticle Substances 0.000 description 2
• 239000006199 nebulizer Substances 0.000 description 2
• 210000003061 neural cell Anatomy 0.000 description 2
• 201000007607 neuronal ceroid lipofuscinosis 3 Diseases 0.000 description 2
• 210000001328 optic nerve Anatomy 0.000 description 2
• 210000000496 pancreas Anatomy 0.000 description 2
• 230000036961 partial effect Effects 0.000 description 2
• 244000052769 pathogen Species 0.000 description 2
• 230000001717 pathogenic effect Effects 0.000 description 2
• 208000030613 peripheral artery disease Diseases 0.000 description 2
• 210000001428 peripheral nervous system Anatomy 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
• 230000026731 phosphorylation Effects 0.000 description 2
• 238000006366 phosphorylation reaction Methods 0.000 description 2
• 230000001817 pituitary effect Effects 0.000 description 2
• 238000002360 preparation method Methods 0.000 description 2
• 230000008569 process Effects 0.000 description 2
• 230000000750 progressive effect Effects 0.000 description 2
• 210000005267 prostate cell Anatomy 0.000 description 2
• 208000020016 psychiatric disease Diseases 0.000 description 2
• 230000009257 reactivity Effects 0.000 description 2
• 108010043277 recombinant soluble CD4 Proteins 0.000 description 2
• 230000006798 recombination Effects 0.000 description 2
• 238000005215 recombination Methods 0.000 description 2
• 230000003362 replicative effect Effects 0.000 description 2
• 230000000241 respiratory effect Effects 0.000 description 2
• 230000004258 retinal degeneration Effects 0.000 description 2
• 210000003583 retinal pigment epithelium Anatomy 0.000 description 2
• 210000005245 right atrium Anatomy 0.000 description 2
• 210000005241 right ventricle Anatomy 0.000 description 2
• 238000002864 sequence alignment Methods 0.000 description 2
• 210000002966 serum Anatomy 0.000 description 2
• 238000007493 shaping process Methods 0.000 description 2
• 208000011985 sialidosis Diseases 0.000 description 2
• 210000002363 skeletal muscle cell Anatomy 0.000 description 2
• 210000000329 smooth muscle myocyte Anatomy 0.000 description 2
• 101150005399 sod2 gene Proteins 0.000 description 2
• 229960000553 somatostatin Drugs 0.000 description 2
• 210000000278 spinal cord Anatomy 0.000 description 2
• 238000010561 standard procedure Methods 0.000 description 2
• 239000003270 steroid hormone Substances 0.000 description 2
• 210000003523 substantia nigra Anatomy 0.000 description 2
• 239000005720 sucrose Substances 0.000 description 2
• 108060007951 sulfatase Proteins 0.000 description 2
• 238000001356 surgical procedure Methods 0.000 description 2
• 230000035488 systolic blood pressure Effects 0.000 description 2
• 210000004001 thalamic nuclei Anatomy 0.000 description 2
• 231100000419 toxicity Toxicity 0.000 description 2
• 230000001988 toxicity Effects 0.000 description 2
• 230000009261 transgenic effect Effects 0.000 description 2
• 238000002054 transplantation Methods 0.000 description 2
• 239000002753 trypsin inhibitor Substances 0.000 description 2
• 206010046766 uterine cancer Diseases 0.000 description 2
• 210000004291 uterus Anatomy 0.000 description 2
• 238000002255 vaccination Methods 0.000 description 2
• 208000007089 vaccinia Diseases 0.000 description 2
• 102000003925 1,4-alpha-Glucan Branching Enzyme Human genes 0.000 description 1
• 108090000344 1,4-alpha-Glucan Branching Enzyme Proteins 0.000 description 1
• HWPZZUQOWRWFDB-UHFFFAOYSA-N 1-methylcytosine Chemical compound CN1C=CC(N)=NC1=O HWPZZUQOWRWFDB-UHFFFAOYSA-N 0.000 description 1
• NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical class C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
• LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 description 1
• INZOTETZQBPBCE-NYLDSJSYSA-N 3-sialyl lewis Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@H](O)CO)[C@@H]([C@@H](NC(C)=O)C=O)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 INZOTETZQBPBCE-NYLDSJSYSA-N 0.000 description 1
• 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 1
• 101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 1
• 208000030507 AIDS Diseases 0.000 description 1
• 241000238876 Acari Species 0.000 description 1
• 206010000599 Acromegaly Diseases 0.000 description 1
• 102100021305 Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 Human genes 0.000 description 1
• 108060003345 Adrenergic Receptor Proteins 0.000 description 1
• 102000017910 Adrenergic receptor Human genes 0.000 description 1
• 208000007848 Alcoholism Diseases 0.000 description 1
• 241000702419 Ambidensovirus Species 0.000 description 1
• 102100034594 Angiopoietin-1 Human genes 0.000 description 1
• 108010048154 Angiopoietin-1 Proteins 0.000 description 1
• 102100034608 Angiopoietin-2 Human genes 0.000 description 1
• 108010048036 Angiopoietin-2 Proteins 0.000 description 1
• 208000000103 Anorexia Nervosa Diseases 0.000 description 1
• 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
• 208000019901 Anxiety disease Diseases 0.000 description 1
• 102000018655 Apolipoproteins C Human genes 0.000 description 1
• 108010027070 Apolipoproteins C Proteins 0.000 description 1
• 102000013918 Apolipoproteins E Human genes 0.000 description 1
• 108010025628 Apolipoproteins E Proteins 0.000 description 1
• 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 1
• 241000726096 Aratinga Species 0.000 description 1
• 241000712891 Arenavirus Species 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• 102100022146 Arylsulfatase A Human genes 0.000 description 1
• 102100031491 Arylsulfatase B Human genes 0.000 description 1
• 206010068220 Aspartylglucosaminuria Diseases 0.000 description 1
• 241000351920 Aspergillus nidulans Species 0.000 description 1
• 241000416162 Astragalus gummifer Species 0.000 description 1
• 206010003571 Astrocytoma Diseases 0.000 description 1
• 102000007372 Ataxin-1 Human genes 0.000 description 1
• 108010032963 Ataxin-1 Proteins 0.000 description 1
• 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 1
• 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 1
• 208000023275 Autoimmune disease Diseases 0.000 description 1
• 102100035526 B melanoma antigen 1 Human genes 0.000 description 1
• 108091012583 BCL2 Proteins 0.000 description 1
• 108700020463 BRCA1 Proteins 0.000 description 1
• 102000036365 BRCA1 Human genes 0.000 description 1
• 102000052609 BRCA2 Human genes 0.000 description 1
• 108700020462 BRCA2 Proteins 0.000 description 1
• 206010005003 Bladder cancer Diseases 0.000 description 1
• 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
• 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
• 208000019838 Blood disease Diseases 0.000 description 1
• 206010005949 Bone cancer Diseases 0.000 description 1
• 208000018084 Bone neoplasm Diseases 0.000 description 1
• 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 1
• 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 1
• 208000017843 C syndrome Diseases 0.000 description 1
• 101710155857 C-C motif chemokine 2 Proteins 0.000 description 1
• 108010029697 CD40 Ligand Proteins 0.000 description 1
• 102100032937 CD40 ligand Human genes 0.000 description 1
• 206010006895 Cachexia Diseases 0.000 description 1
• 102100035344 Cadherin-related family member 1 Human genes 0.000 description 1
• 101100005789 Caenorhabditis elegans cdk-4 gene Proteins 0.000 description 1
• 208000022526 Canavan disease Diseases 0.000 description 1
• 102100025570 Cancer/testis antigen 1 Human genes 0.000 description 1
• 241000282472 Canis lupus familiaris Species 0.000 description 1
• 206010007559 Cardiac failure congestive Diseases 0.000 description 1
• 102100026550 Caspase-9 Human genes 0.000 description 1
• 108090000566 Caspase-9 Proteins 0.000 description 1
• 108010076667 Caspases Proteins 0.000 description 1
• 102000011727 Caspases Human genes 0.000 description 1
• 102100035882 Catalase Human genes 0.000 description 1
• 108010053835 Catalase Proteins 0.000 description 1
• 102000005572 Cathepsin A Human genes 0.000 description 1
• 108010059081 Cathepsin A Proteins 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 206010050389 Cerebral ataxia Diseases 0.000 description 1
• 108010036867 Cerebroside-Sulfatase Proteins 0.000 description 1
• 102000000018 Chemokine CCL2 Human genes 0.000 description 1
• 241000684559 Chicken parvovirus Species 0.000 description 1
• 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
• 108010062306 Clostridium botulinum exoenzyme C3 Proteins 0.000 description 1
• 102100022641 Coagulation factor IX Human genes 0.000 description 1
• 206010010099 Combined immunodeficiency Diseases 0.000 description 1
• 108091028732 Concatemer Proteins 0.000 description 1
• 206010010456 Congenital emphysema Diseases 0.000 description 1
• 241000711573 Coronaviridae Species 0.000 description 1
• 108700002856 Coronavirus Envelope Proteins Proteins 0.000 description 1
• 241000557626 Corvus corax Species 0.000 description 1
• 108020003264 Cotransporters Proteins 0.000 description 1
• 102000034534 Cotransporters Human genes 0.000 description 1
• 241000699800 Cricetinae Species 0.000 description 1
• 201000003075 Crimean-Congo hemorrhagic fever Diseases 0.000 description 1
• 229920001076 Cutan Polymers 0.000 description 1
• 102000018832 Cytochromes Human genes 0.000 description 1
• 108010052832 Cytochromes Proteins 0.000 description 1
• 102000000311 Cytosine Deaminase Human genes 0.000 description 1
• 108010080611 Cytosine Deaminase Proteins 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• 150000008574 D-amino acids Chemical class 0.000 description 1
• 230000004543 DNA replication Effects 0.000 description 1
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
• 241000252212 Danio rerio Species 0.000 description 1
• 102000009058 Death Domain Receptors Human genes 0.000 description 1
• 108010049207 Death Domain Receptors Proteins 0.000 description 1
• 206010012239 Delusion Diseases 0.000 description 1
• 206010012289 Dementia Diseases 0.000 description 1
• 108700043208 Dimauro disease Proteins 0.000 description 1
• 101100396994 Drosophila melanogaster Inos gene Proteins 0.000 description 1
• 102100024108 Dystrophin Human genes 0.000 description 1
• 102100037024 E3 ubiquitin-protein ligase XIAP Human genes 0.000 description 1
• 241001115402 Ebolavirus Species 0.000 description 1
• LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
• 102100038083 Endosialin Human genes 0.000 description 1
• 101710144543 Endosialin Proteins 0.000 description 1
• 101710121417 Envelope glycoprotein Proteins 0.000 description 1
• 101710204837 Envelope small membrane protein Proteins 0.000 description 1
• 102400001368 Epidermal growth factor Human genes 0.000 description 1
• 101800003838 Epidermal growth factor Proteins 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 241000713730 Equine infectious anemia virus Species 0.000 description 1
• 241000121268 Erythroparvovirus Species 0.000 description 1
• 108090000371 Esterases Proteins 0.000 description 1
• 102100027186 Extracellular superoxide dismutase [Cu-Zn] Human genes 0.000 description 1
• 108700001268 Extracellular superoxide dismutase [Cu-Zn] Proteins 0.000 description 1
• 108010076282 Factor IX Proteins 0.000 description 1
• 206010016077 Factor IX deficiency Diseases 0.000 description 1
• 108010054218 Factor VIII Proteins 0.000 description 1
• 102000001690 Factor VIII Human genes 0.000 description 1
• 201000003542 Factor VIII deficiency Diseases 0.000 description 1
• 108010014173 Factor X Proteins 0.000 description 1
• 201000006328 Fanconi syndrome Diseases 0.000 description 1
• 208000037251 Fanconi-Bickel syndrome Diseases 0.000 description 1
• 208000001948 Farber Lipogranulomatosis Diseases 0.000 description 1
• 108010087819 Fc receptors Proteins 0.000 description 1
• 102000009109 Fc receptors Human genes 0.000 description 1
• 241000701915 Feline panleukopenia virus Species 0.000 description 1
• 241000701925 Feline parvovirus Species 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 102000056303 Ferlin Human genes 0.000 description 1
• 108700036130 Ferlin Proteins 0.000 description 1
• 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
• 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
• 241000711950 Filoviridae Species 0.000 description 1
• 241000710831 Flavivirus Species 0.000 description 1
• 201000011240 Frontotemporal dementia Diseases 0.000 description 1
• 208000010263 Fructose-1,6-Diphosphatase Deficiency Diseases 0.000 description 1
• 102100039717 G antigen 1 Human genes 0.000 description 1
• 101150066002 GFP gene Proteins 0.000 description 1
• 201000008892 GM1 Gangliosidosis Diseases 0.000 description 1
• 101710177291 Gag polyprotein Proteins 0.000 description 1
• 102000002464 Galactosidases Human genes 0.000 description 1
• 108010093031 Galactosidases Proteins 0.000 description 1
• 102400001370 Galanin Human genes 0.000 description 1
• 101800002068 Galanin Proteins 0.000 description 1
• 241000963438 Gaussia <copepod> Species 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
• 201000004311 Gilles de la Tourette syndrome Diseases 0.000 description 1
• 102100039289 Glial fibrillary acidic protein Human genes 0.000 description 1
• 101710193519 Glial fibrillary acidic protein Proteins 0.000 description 1
• 206010018338 Glioma Diseases 0.000 description 1
• 208000010055 Globoid Cell Leukodystrophy Diseases 0.000 description 1
• 102000006395 Globulins Human genes 0.000 description 1
• 108010044091 Globulins Proteins 0.000 description 1
• 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
• 108091052347 Glucose transporter family Proteins 0.000 description 1
• 102000042092 Glucose transporter family Human genes 0.000 description 1
• 108010086800 Glucose-6-Phosphatase Proteins 0.000 description 1
• 102000003638 Glucose-6-Phosphatase Human genes 0.000 description 1
• 102100039684 Glucose-6-phosphate exchanger SLC37A4 Human genes 0.000 description 1
• 102000053187 Glucuronidase Human genes 0.000 description 1
• 108010060309 Glucuronidase Proteins 0.000 description 1
• 102000018899 Glutamate Receptors Human genes 0.000 description 1
• 108010027915 Glutamate Receptors Proteins 0.000 description 1
• 102000005720 Glutathione transferase Human genes 0.000 description 1
• 108010070675 Glutathione transferase Proteins 0.000 description 1
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
• 206010053249 Glycogen Storage Disease Type IV Diseases 0.000 description 1
• 208000006562 Glycogen Storage Disease Type VII Diseases 0.000 description 1
• 108010001483 Glycogen Synthase Proteins 0.000 description 1
• 208000011123 Glycogen storage disease due to glycogen branching enzyme deficiency Diseases 0.000 description 1
• 208000035974 Glycogen storage disease due to liver and muscle phosphorylase kinase deficiency Diseases 0.000 description 1
• 208000032000 Glycogen storage disease due to muscle glycogen phosphorylase deficiency Diseases 0.000 description 1
• 208000031296 Glycogen storage disease due to muscle phosphorylase kinase deficiency Diseases 0.000 description 1
• 206010018462 Glycogen storage disease type V Diseases 0.000 description 1
• 241001517118 Goose parvovirus Species 0.000 description 1
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
• 208000004547 Hallucinations Diseases 0.000 description 1
• 206010019196 Head injury Diseases 0.000 description 1
• 206010019280 Heart failures Diseases 0.000 description 1
• 102000002737 Heme Oxygenase-1 Human genes 0.000 description 1
• 108010018924 Heme Oxygenase-1 Proteins 0.000 description 1
• 208000028782 Hereditary disease Diseases 0.000 description 1
• 108010053317 Hexosaminidase A Proteins 0.000 description 1
• 102000016871 Hexosaminidase A Human genes 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 101001042227 Homo sapiens Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 Proteins 0.000 description 1
• 101000874316 Homo sapiens B melanoma antigen 1 Proteins 0.000 description 1
• 101000901683 Homo sapiens Battenin Proteins 0.000 description 1
• 101000737767 Homo sapiens Cadherin-related family member 1 Proteins 0.000 description 1
• 101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 description 1
• 101000886137 Homo sapiens G antigen 1 Proteins 0.000 description 1
• 101000886173 Homo sapiens Glucose-6-phosphate exchanger SLC37A4 Proteins 0.000 description 1
• 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 1
• 101000574060 Homo sapiens Progesterone receptor Proteins 0.000 description 1
• 101001123859 Homo sapiens Sialidase-1 Proteins 0.000 description 1
• 101100369992 Homo sapiens TNFSF10 gene Proteins 0.000 description 1
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
• 108010000521 Human Growth Hormone Proteins 0.000 description 1
• 102000002265 Human Growth Hormone Human genes 0.000 description 1
• 239000000854 Human Growth Hormone Substances 0.000 description 1
• 108010070875 Human Immunodeficiency Virus tat Gene Products Proteins 0.000 description 1
• 241001135569 Human adenovirus 5 Species 0.000 description 1
• 241000701024 Human betaherpesvirus 5 Species 0.000 description 1
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
• 208000015204 Hurler-Scheie syndrome Diseases 0.000 description 1
• 108010003272 Hyaluronate lyase Proteins 0.000 description 1
• 108700037017 Hyaluronidase Deficiency Proteins 0.000 description 1
• 208000005503 Hyaluronidase deficiency Diseases 0.000 description 1
• 102000001974 Hyaluronidases Human genes 0.000 description 1
• 206010020575 Hyperammonaemia Diseases 0.000 description 1
• 206010062767 Hypophysitis Diseases 0.000 description 1
• XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
• 101150050155 ILK gene Proteins 0.000 description 1
• 108010053927 Iduronate Sulfatase Proteins 0.000 description 1
• 206010061598 Immunodeficiency Diseases 0.000 description 1
• 241000711450 Infectious bronchitis virus Species 0.000 description 1
• 108010009595 Inorganic Pyrophosphatase Proteins 0.000 description 1
• 102000048143 Insulin-Like Growth Factor II Human genes 0.000 description 1
• 108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 1
• 102000014150 Interferons Human genes 0.000 description 1
• 108010050904 Interferons Proteins 0.000 description 1
• 102000003814 Interleukin-10 Human genes 0.000 description 1
• 108090000174 Interleukin-10 Proteins 0.000 description 1
• 102000003815 Interleukin-11 Human genes 0.000 description 1
• 108090000177 Interleukin-11 Proteins 0.000 description 1
• 102000013462 Interleukin-12 Human genes 0.000 description 1
• 108010065805 Interleukin-12 Proteins 0.000 description 1
• 102000003816 Interleukin-13 Human genes 0.000 description 1
• 108090000176 Interleukin-13 Proteins 0.000 description 1
• 102000003810 Interleukin-18 Human genes 0.000 description 1
• 108090000171 Interleukin-18 Proteins 0.000 description 1
• 102000000646 Interleukin-3 Human genes 0.000 description 1
• 108010002386 Interleukin-3 Proteins 0.000 description 1
• 102000004388 Interleukin-4 Human genes 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 102100039897 Interleukin-5 Human genes 0.000 description 1
• 108010002616 Interleukin-5 Proteins 0.000 description 1
• 102000004889 Interleukin-6 Human genes 0.000 description 1
• 108090001005 Interleukin-6 Proteins 0.000 description 1
• 102100021592 Interleukin-7 Human genes 0.000 description 1
• 108010002586 Interleukin-7 Proteins 0.000 description 1
• 102000004890 Interleukin-8 Human genes 0.000 description 1
• 108090001007 Interleukin-8 Proteins 0.000 description 1
• 102000000585 Interleukin-9 Human genes 0.000 description 1
• 108010002335 Interleukin-9 Proteins 0.000 description 1
• 241000121270 Iteradensovirus Species 0.000 description 1
• 241000710842 Japanese encephalitis virus Species 0.000 description 1
• 208000012659 Joint disease Diseases 0.000 description 1
• 208000028226 Krabbe disease Diseases 0.000 description 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
• 102100031413 L-dopachrome tautomerase Human genes 0.000 description 1
• 101710093778 L-dopachrome tautomerase Proteins 0.000 description 1
• 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 description 1
• 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 1
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
• 108700006394 Lactate Dehydrogenase Deficiency Proteins 0.000 description 1
• 208000006136 Leigh Disease Diseases 0.000 description 1
• 208000017507 Leigh syndrome Diseases 0.000 description 1
• 241000713666 Lentivirus Species 0.000 description 1
• 108010092277 Leptin Proteins 0.000 description 1
• 102000016267 Leptin Human genes 0.000 description 1
• 208000009625 Lesch-Nyhan syndrome Diseases 0.000 description 1
• 101710196632 LexA repressor Proteins 0.000 description 1
• 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
• 102100022119 Lipoprotein lipase Human genes 0.000 description 1
• 206010067125 Liver injury Diseases 0.000 description 1
• 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 1
• 101710145006 Lysis protein Proteins 0.000 description 1
• 208000003221 Lysosomal acid lipase deficiency Diseases 0.000 description 1
• 108010064171 Lysosome-Associated Membrane Glycoproteins Proteins 0.000 description 1
• 102000014944 Lysosome-Associated Membrane Glycoproteins Human genes 0.000 description 1
• 208000002569 Machado-Joseph Disease Diseases 0.000 description 1
• 101710125418 Major capsid protein Proteins 0.000 description 1
• 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 208000030162 Maple syrup disease Diseases 0.000 description 1
• 241001115401 Marburgvirus Species 0.000 description 1
• 101710085938 Matrix protein Proteins 0.000 description 1
• 241000489861 Maximus Species 0.000 description 1
• 201000005505 Measles Diseases 0.000 description 1
• 102000000440 Melanoma-associated antigen Human genes 0.000 description 1
• 108050008953 Melanoma-associated antigen Proteins 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 101710127721 Membrane protein Proteins 0.000 description 1
• 201000011442 Metachromatic leukodystrophy Diseases 0.000 description 1
• 206010072929 Mucolipidosis type III Diseases 0.000 description 1
• 206010056893 Mucopolysaccharidosis VII Diseases 0.000 description 1
• 208000025797 Mucopolysaccharidosis type 4A Diseases 0.000 description 1
• 208000025923 Mucopolysaccharidosis type 4B Diseases 0.000 description 1
• 208000005647 Mumps Diseases 0.000 description 1
• 206010028289 Muscle atrophy Diseases 0.000 description 1
• 241001503699 Muscovy duck parvovirus Species 0.000 description 1
• 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
• 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
• 108010027520 N-Acetylgalactosamine-4-Sulfatase Proteins 0.000 description 1
• HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 description 1
• 108010057466 NF-kappa B Proteins 0.000 description 1
• 102000003945 NF-kappa B Human genes 0.000 description 1
• 108091061960 Naked DNA Proteins 0.000 description 1
• 108700019961 Neoplasm Genes Proteins 0.000 description 1
• 102000048850 Neoplasm Genes Human genes 0.000 description 1
• 102000015336 Nerve Growth Factor Human genes 0.000 description 1
• 208000028389 Nerve injury Diseases 0.000 description 1
• 208000012902 Nervous system disease Diseases 0.000 description 1
• 208000025966 Neurological disease Diseases 0.000 description 1
• 244000061176 Nicotiana tabacum Species 0.000 description 1
• 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
• 102000008297 Nuclear Matrix-Associated Proteins Human genes 0.000 description 1
• 108010035916 Nuclear Matrix-Associated Proteins Proteins 0.000 description 1
• 102000007399 Nuclear hormone receptor Human genes 0.000 description 1
• 108020005497 Nuclear hormone receptor Proteins 0.000 description 1
• 108090001074 Nucleocapsid Proteins Proteins 0.000 description 1
• 101710141454 Nucleoprotein Proteins 0.000 description 1
• 108010061100 Nucleoproteins Proteins 0.000 description 1
• RMINQIRDFIBNLE-NNRWGFCXSA-N O-[N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosaminyl]-L-serine Chemical compound O1[C@H](OC[C@H](N)C(O)=O)[C@H](NC(=O)C)[C@@H](O)[C@@H](O)[C@H]1CO[C@@]1(C(O)=O)O[C@@H]([C@H](O)[C@H](O)CO)[C@H](NC(C)=O)[C@@H](O)C1 RMINQIRDFIBNLE-NNRWGFCXSA-N 0.000 description 1
• 208000008589 Obesity Diseases 0.000 description 1
• 206010030113 Oedema Diseases 0.000 description 1
• 108091034117 Oligonucleotide Proteins 0.000 description 1
• 241000713112 Orthobunyavirus Species 0.000 description 1
• 108060006580 PRAME Proteins 0.000 description 1
• 102000036673 PRAME Human genes 0.000 description 1
• 102100034640 PWWP domain-containing DNA repair factor 3A Human genes 0.000 description 1
• 108050007154 PWWP domain-containing DNA repair factor 3A Proteins 0.000 description 1
• 108091081548 Palindromic sequence Proteins 0.000 description 1
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
• 241001631646 Papillomaviridae Species 0.000 description 1
• 241000282520 Papio Species 0.000 description 1
• 206010033864 Paranoia Diseases 0.000 description 1
• 208000027099 Paranoid disease Diseases 0.000 description 1
• 241000701945 Parvoviridae Species 0.000 description 1
• 102000057297 Pepsin A Human genes 0.000 description 1
• 108090000284 Pepsin A Proteins 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 201000005702 Pertussis Diseases 0.000 description 1
• 108010069013 Phenylalanine Hydroxylase Proteins 0.000 description 1
• 102100038223 Phenylalanine-4-hydroxylase Human genes 0.000 description 1
• 201000011252 Phenylketonuria Diseases 0.000 description 1
• 108010092528 Phosphate Transport Proteins Proteins 0.000 description 1
• 208000005746 Phosphoenolpyruvate carboxykinase deficiency Diseases 0.000 description 1
• 108700001571 Phosphoenolpyruvate carboxykinase deficiency Proteins 0.000 description 1
• 102000001105 Phosphofructokinases Human genes 0.000 description 1
• 108010069341 Phosphofructokinases Proteins 0.000 description 1
• 108700010203 Phosphoglycerate Kinase 1 Deficiency Proteins 0.000 description 1
• 102100026918 Phospholipase A2 Human genes 0.000 description 1
• 101710096328 Phospholipase A2 Proteins 0.000 description 1
• 108091000080 Phosphotransferase Proteins 0.000 description 1
• 241000254058 Photinus Species 0.000 description 1
• 208000000609 Pick Disease of the Brain Diseases 0.000 description 1
• 206010035226 Plasma cell myeloma Diseases 0.000 description 1
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
• 241000223503 Platysma Species 0.000 description 1
• 208000000474 Poliomyelitis Diseases 0.000 description 1
• 241000276498 Pollachius virens Species 0.000 description 1
• 208000020584 Polyploidy Diseases 0.000 description 1
• 239000004793 Polystyrene Substances 0.000 description 1
• 241000702619 Porcine parvovirus Species 0.000 description 1
• 201000009916 Postpartum depression Diseases 0.000 description 1
• 208000032319 Primary lateral sclerosis Diseases 0.000 description 1
• 102100035703 Prostatic acid phosphatase Human genes 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 102000001253 Protein Kinase Human genes 0.000 description 1
• 108010076504 Protein Sorting Signals Proteins 0.000 description 1
• 229940116193 Protein phosphatase inhibitor Drugs 0.000 description 1
• 102000004097 Protein phosphatase inhibitor 1 Human genes 0.000 description 1
• 108090000506 Protein phosphatase inhibitor 1 Proteins 0.000 description 1
• 241000287530 Psittaciformes Species 0.000 description 1
• 208000006262 Psychological Sexual Dysfunctions Diseases 0.000 description 1
• 208000028017 Psychotic disease Diseases 0.000 description 1
• 108091007622 Pyrophosphate transporters Proteins 0.000 description 1
• 102000009572 RNA Polymerase II Human genes 0.000 description 1
• 108010009460 RNA Polymerase II Proteins 0.000 description 1
• 108020005067 RNA Splice Sites Proteins 0.000 description 1
• 108091005682 Receptor kinases Proteins 0.000 description 1
• 101710100968 Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
• 208000005587 Refsum Disease Diseases 0.000 description 1
• 241000242739 Renilla Species 0.000 description 1
• 102100040756 Rhodopsin Human genes 0.000 description 1
• 108020004422 Riboswitch Proteins 0.000 description 1
• 241000713124 Rift Valley fever virus Species 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 108091006299 SLC2A2 Proteins 0.000 description 1
• 108091006300 SLC2A4 Proteins 0.000 description 1
• 101710173693 Short transient receptor potential channel 1 Proteins 0.000 description 1
• 101710173694 Short transient receptor potential channel 2 Proteins 0.000 description 1
• 208000000828 Sialic Acid Storage Disease Diseases 0.000 description 1
• 102100028760 Sialidase-1 Human genes 0.000 description 1
• 208000017460 Sialidosis type 2 Diseases 0.000 description 1
• 201000006567 Sialuria Diseases 0.000 description 1
• 108020004682 Single-Stranded DNA Proteins 0.000 description 1
• 201000001828 Sly syndrome Diseases 0.000 description 1
• 241000425549 Snake parvovirus Species 0.000 description 1
• 102400000821 Somatostatin-28 Human genes 0.000 description 1
• 101800004701 Somatostatin-28 Proteins 0.000 description 1
• 108010019965 Spectrin Proteins 0.000 description 1
• 102000005890 Spectrin Human genes 0.000 description 1
• 208000009415 Spinocerebellar Ataxias Diseases 0.000 description 1
• 201000003622 Spinocerebellar ataxia type 2 Diseases 0.000 description 1
• 208000036834 Spinocerebellar ataxia type 3 Diseases 0.000 description 1
• 108091081024 Start codon Proteins 0.000 description 1
• 102000000019 Sterol Esterase Human genes 0.000 description 1
• 108010055297 Sterol Esterase Proteins 0.000 description 1
• 208000005718 Stomach Neoplasms Diseases 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• 108700012920 TNF Proteins 0.000 description 1
• 108700012411 TNFSF10 Proteins 0.000 description 1
• 108010017842 Telomerase Proteins 0.000 description 1
• 208000024313 Testicular Neoplasms Diseases 0.000 description 1
• 206010057644 Testis cancer Diseases 0.000 description 1
• 208000002903 Thalassemia Diseases 0.000 description 1
• 108010046075 Thymosin Proteins 0.000 description 1
• 102000007501 Thymosin Human genes 0.000 description 1
• 208000024770 Thyroid neoplasm Diseases 0.000 description 1
• 208000035317 Total hypoxanthine-guanine phosphoribosyl transferase deficiency Diseases 0.000 description 1
• 208000000323 Tourette Syndrome Diseases 0.000 description 1
• 208000016620 Tourette disease Diseases 0.000 description 1
• 229920001615 Tragacanth Polymers 0.000 description 1
• 102100035100 Transcription factor p65 Human genes 0.000 description 1
• 101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
• 108010074506 Transfer Factor Proteins 0.000 description 1
• 102000004357 Transferases Human genes 0.000 description 1
• 108090000992 Transferases Proteins 0.000 description 1
• 102000009618 Transforming Growth Factors Human genes 0.000 description 1
• 108010009583 Transforming Growth Factors Proteins 0.000 description 1
• 241000711484 Transmissible gastroenteritis virus Species 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 description 1
• 102000015098 Tumor Suppressor Protein p53 Human genes 0.000 description 1
• 108010078814 Tumor Suppressor Protein p53 Proteins 0.000 description 1
• 102100040247 Tumor necrosis factor Human genes 0.000 description 1
• 102100024598 Tumor necrosis factor ligand superfamily member 10 Human genes 0.000 description 1
• 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 1
• 108050002568 Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 1
• 108091000117 Tyrosine 3-Monooxygenase Proteins 0.000 description 1
• 102000048218 Tyrosine 3-monooxygenases Human genes 0.000 description 1
• 108091026838 U1 spliceosomal RNA Proteins 0.000 description 1
• 101710155955 U4/U6.U5 tri-snRNP-associated protein 1 Proteins 0.000 description 1
• 102100027244 U4/U6.U5 tri-snRNP-associated protein 1 Human genes 0.000 description 1
• 102000039634 Untranslated RNA Human genes 0.000 description 1
• 108020004417 Untranslated RNA Proteins 0.000 description 1
• 206010046298 Upper motor neurone lesion Diseases 0.000 description 1
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
• 201000004810 Vascular dementia Diseases 0.000 description 1
• 206010063661 Vascular encephalopathy Diseases 0.000 description 1
• 108020005202 Viral DNA Proteins 0.000 description 1
• 108010067390 Viral Proteins Proteins 0.000 description 1
• 208000036142 Viral infection Diseases 0.000 description 1
• 208000026589 Wolman disease Diseases 0.000 description 1
• 108700031544 X-Linked Inhibitor of Apoptosis Proteins 0.000 description 1
• 241000710772 Yellow fever virus Species 0.000 description 1
• 240000008042 Zea mays Species 0.000 description 1
• 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
• 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
• 101710185494 Zinc finger protein Proteins 0.000 description 1
• 102100023597 Zinc finger protein 816 Human genes 0.000 description 1
• ZHAFUINZIZIXFC-UHFFFAOYSA-N [9-(dimethylamino)-10-methylbenzo[a]phenoxazin-5-ylidene]azanium;chloride Chemical compound [Cl-].O1C2=CC(=[NH2+])C3=CC=CC=C3C2=NC2=C1C=C(N(C)C)C(C)=C2 ZHAFUINZIZIXFC-UHFFFAOYSA-N 0.000 description 1
• 210000001015 abdomen Anatomy 0.000 description 1
• 230000005856 abnormality Effects 0.000 description 1
• 150000003869 acetamides Chemical class 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 239000004480 active ingredient Substances 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 208000009956 adenocarcinoma Diseases 0.000 description 1
• 201000009628 adenosine deaminase deficiency Diseases 0.000 description 1
• 108700015342 adenovirus terminal Proteins 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 208000030597 adult Refsum disease Diseases 0.000 description 1
• 230000004520 agglutination Effects 0.000 description 1
• 201000007930 alcohol dependence Diseases 0.000 description 1
• 230000001476 alcoholic effect Effects 0.000 description 1
• 150000001298 alcohols Chemical class 0.000 description 1
• 210000004727 amygdala Anatomy 0.000 description 1
• 239000005557 antagonist Substances 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000001093 anti-cancer Effects 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 230000030741 antigen processing and presentation Effects 0.000 description 1
• 210000000612 antigen-presenting cell Anatomy 0.000 description 1
• 239000004599 antimicrobial Substances 0.000 description 1
• 230000036506 anxiety Effects 0.000 description 1
• 239000003125 aqueous solvent Substances 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
• 210000004507 artificial chromosome Anatomy 0.000 description 1
• 229940009098 aspartate Drugs 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-L aspartate group Chemical group N[C@@H](CC(=O)[O-])C(=O)[O-] CKLJMWTZIZZHCS-REOHCLBHSA-L 0.000 description 1
• 238000003556 assay Methods 0.000 description 1
• 208000015802 attention deficit-hyperactivity disease Diseases 0.000 description 1
• 230000003190 augmentative effect Effects 0.000 description 1
• 208000036556 autosomal recessive T cell-negative B cell-negative NK cell-negative due to adenosine deaminase deficiency severe combined immunodeficiency Diseases 0.000 description 1
• 210000003719 b-lymphocyte Anatomy 0.000 description 1
• 101150019263 b4 gene Proteins 0.000 description 1
• 230000004888 barrier function Effects 0.000 description 1
• 210000004227 basal ganglia Anatomy 0.000 description 1
• 239000011324 bead Substances 0.000 description 1
• 230000003542 behavioural effect Effects 0.000 description 1
• 230000008499 blood brain barrier function Effects 0.000 description 1
• 239000003114 blood coagulation factor Substances 0.000 description 1
• 210000004204 blood vessel Anatomy 0.000 description 1
• 210000001218 blood-brain barrier Anatomy 0.000 description 1
• 210000000133 brain stem Anatomy 0.000 description 1
• 229940077737 brain-derived neurotrophic factor Drugs 0.000 description 1
• BPKIGYQJPYCAOW-FFJTTWKXSA-I calcium;potassium;disodium;(2s)-2-hydroxypropanoate;dichloride;dihydroxide;hydrate Chemical compound O.[OH-].[OH-].[Na+].[Na+].[Cl-].[Cl-].[K+].[Ca+2].C[C@H](O)C([O-])=O BPKIGYQJPYCAOW-FFJTTWKXSA-I 0.000 description 1
• 238000002619 cancer immunotherapy Methods 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 210000000845 cartilage Anatomy 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 210000001159 caudate nucleus Anatomy 0.000 description 1
• 238000004113 cell culture Methods 0.000 description 1
• 229940076006 cell cycle modulator Drugs 0.000 description 1
• 230000032823 cell division Effects 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 230000036978 cell physiology Effects 0.000 description 1
• 230000008614 cellular interaction Effects 0.000 description 1
• 210000003591 cerebellar nuclei Anatomy 0.000 description 1
• 210000001638 cerebellum Anatomy 0.000 description 1
• 210000003037 cerebral aqueduct Anatomy 0.000 description 1
• 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 239000002738 chelating agent Substances 0.000 description 1
• 238000006243 chemical reaction Methods 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 210000000038 chest Anatomy 0.000 description 1
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
• 230000007882 cirrhosis Effects 0.000 description 1
• 208000019425 cirrhosis of liver Diseases 0.000 description 1
• 229940110456 cocoa butter Drugs 0.000 description 1
• 235000019868 cocoa butter Nutrition 0.000 description 1
• 238000004891 communication Methods 0.000 description 1
• 206010010121 compartment syndrome Diseases 0.000 description 1
• 238000012875 competitive assay Methods 0.000 description 1
• 230000009137 competitive binding Effects 0.000 description 1
• 230000000536 complexating effect Effects 0.000 description 1
• 239000007891 compressed tablet Substances 0.000 description 1
• 238000010276 construction Methods 0.000 description 1
• 238000013270 controlled release Methods 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 210000004351 coronary vessel Anatomy 0.000 description 1
• 210000000877 corpus callosum Anatomy 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 230000016396 cytokine production Effects 0.000 description 1
• 108091012374 cytosine binding proteins Proteins 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 230000003111 delayed effect Effects 0.000 description 1
• 231100000868 delusion Toxicity 0.000 description 1
• 238000001212 derivatisation Methods 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 125000005077 diacylhydrazine group Chemical group 0.000 description 1
• 210000000188 diaphragm Anatomy 0.000 description 1
• 230000004069 differentiation Effects 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• 102000038379 digestive enzymes Human genes 0.000 description 1
• 108091007734 digestive enzymes Proteins 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• 206010013023 diphtheria Diseases 0.000 description 1
• 239000002270 dispersing agent Substances 0.000 description 1
• 208000018459 dissociative disease Diseases 0.000 description 1
• 230000003828 downregulation Effects 0.000 description 1
• 150000002058 ecdysones Chemical class 0.000 description 1
• 239000003792 electrolyte Substances 0.000 description 1
• 210000001163 endosome Anatomy 0.000 description 1
• 108010048367 enhanced green fluorescent protein Proteins 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 108700004025 env Genes Proteins 0.000 description 1
• 229940116977 epidermal growth factor Drugs 0.000 description 1
• 210000002615 epidermis Anatomy 0.000 description 1
• 210000000647 epithalamus Anatomy 0.000 description 1
• LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
• 229940093471 ethyl oleate Drugs 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 230000002964 excitative effect Effects 0.000 description 1
• 231100000318 excitotoxic Toxicity 0.000 description 1
• 230000003492 excitotoxic effect Effects 0.000 description 1
• 239000013604 expression vector Substances 0.000 description 1
• 229960004222 factor ix Drugs 0.000 description 1
• 229960000301 factor viii Drugs 0.000 description 1
• 229940012426 factor x Drugs 0.000 description 1
• 210000000109 fascia lata Anatomy 0.000 description 1
• 230000002349 favourable effect Effects 0.000 description 1
• 210000003754 fetus Anatomy 0.000 description 1
• 229940126864 fibroblast growth factor Drugs 0.000 description 1
• 230000004761 fibrosis Effects 0.000 description 1
• 230000016615 flocculation Effects 0.000 description 1
• 238000005189 flocculation Methods 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
• 108091006047 fluorescent proteins Proteins 0.000 description 1
• 102000034287 fluorescent proteins Human genes 0.000 description 1
• 230000022244 formylation Effects 0.000 description 1
• 238000006170 formylation reaction Methods 0.000 description 1
• 210000001652 frontal lobe Anatomy 0.000 description 1
• 201000008049 fucosidosis Diseases 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• 210000001222 gaba-ergic neuron Anatomy 0.000 description 1
• 150000002270 gangliosides Chemical class 0.000 description 1
• 206010017758 gastric cancer Diseases 0.000 description 1
• 239000000499 gel Substances 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 230000030279 gene silencing Effects 0.000 description 1
• 238000012226 gene silencing method Methods 0.000 description 1
• 238000010363 gene targeting Methods 0.000 description 1
• 230000009395 genetic defect Effects 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 210000005046 glial fibrillary acidic protein Anatomy 0.000 description 1
• 102000018146 globin Human genes 0.000 description 1
• 108060003196 globin Proteins 0.000 description 1
• 150000002306 glutamic acid derivatives Chemical class 0.000 description 1
• 235000011187 glycerol Nutrition 0.000 description 1
• 208000001266 glycogen storage disease IXb Diseases 0.000 description 1
• 201000000581 glycogen storage disease IXc Diseases 0.000 description 1
• 201000000597 glycogen storage disease IXd Diseases 0.000 description 1
• 201000004534 glycogen storage disease V Diseases 0.000 description 1
• 208000019061 glycogen storage disease due to GLUT2 deficiency Diseases 0.000 description 1
• 208000030046 glycogen storage disease due to liver phosphorylase kinase deficiency Diseases 0.000 description 1
• 230000013595 glycosylation Effects 0.000 description 1
• 238000006206 glycosylation reaction Methods 0.000 description 1
• 229930004094 glycosylphosphatidylinositol Natural products 0.000 description 1
• 239000000122 growth hormone Substances 0.000 description 1
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical class O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 1
• 210000004326 gyrus cinguli Anatomy 0.000 description 1
• 210000003128 head Anatomy 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 210000002064 heart cell Anatomy 0.000 description 1
• 208000014951 hematologic disease Diseases 0.000 description 1
• 208000018706 hematopoietic system disease Diseases 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 231100000753 hepatic injury Toxicity 0.000 description 1
• 208000005252 hepatitis A Diseases 0.000 description 1
• 210000005260 human cell Anatomy 0.000 description 1
• 229960002773 hyaluronidase Drugs 0.000 description 1
• 229910052739 hydrogen Inorganic materials 0.000 description 1
• 239000001257 hydrogen Substances 0.000 description 1
• 230000033444 hydroxylation Effects 0.000 description 1
• 238000005805 hydroxylation reaction Methods 0.000 description 1
• 206010020718 hyperplasia Diseases 0.000 description 1
• 210000003016 hypothalamus Anatomy 0.000 description 1
• 230000003053 immunization Effects 0.000 description 1
• 229940072221 immunoglobulins Drugs 0.000 description 1
• 229960003444 immunosuppressant agent Drugs 0.000 description 1
• 239000003018 immunosuppressive agent Substances 0.000 description 1
• 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 description 1
• 230000006698 induction Effects 0.000 description 1
• 239000003701 inert diluent Substances 0.000 description 1
• 239000011261 inert gas Substances 0.000 description 1
• 208000014674 injury Diseases 0.000 description 1
• 238000007689 inspection Methods 0.000 description 1
• 229940047124 interferons Drugs 0.000 description 1
• 229940076144 interleukin-10 Drugs 0.000 description 1
• 229940074383 interleukin-11 Drugs 0.000 description 1
• 229940117681 interleukin-12 Drugs 0.000 description 1
• 229940076264 interleukin-3 Drugs 0.000 description 1
• 229940028885 interleukin-4 Drugs 0.000 description 1
• 229940100602 interleukin-5 Drugs 0.000 description 1
• 229940100601 interleukin-6 Drugs 0.000 description 1
• 229940100994 interleukin-7 Drugs 0.000 description 1
• 229940096397 interleukin-8 Drugs 0.000 description 1
• XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 1
• 229940118526 interleukin-9 Drugs 0.000 description 1
• 210000002425 internal capsule Anatomy 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• 230000010189 intracellular transport Effects 0.000 description 1
• 238000010255 intramuscular injection Methods 0.000 description 1
• 239000007927 intramuscular injection Substances 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 230000000366 juvenile effect Effects 0.000 description 1
• 210000003292 kidney cell Anatomy 0.000 description 1
• 108010008097 laminin alpha 2 Proteins 0.000 description 1
• 201000010901 lateral sclerosis Diseases 0.000 description 1
• 210000003140 lateral ventricle Anatomy 0.000 description 1
• 239000004816 latex Substances 0.000 description 1
• 229920000126 latex Polymers 0.000 description 1
• 229940039781 leptin Drugs 0.000 description 1
• NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 1
• 201000002818 limb ischemia Diseases 0.000 description 1
• 210000003715 limbic system Anatomy 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 239000006193 liquid solution Substances 0.000 description 1
• 239000006194 liquid suspension Substances 0.000 description 1
• 210000005229 liver cell Anatomy 0.000 description 1
• 208000019423 liver disease Diseases 0.000 description 1
• 230000003908 liver function Effects 0.000 description 1
• 239000006210 lotion Substances 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 238000009593 lumbar puncture Methods 0.000 description 1
• 238000004020 luminiscence type Methods 0.000 description 1
• 230000002934 lysing effect Effects 0.000 description 1
• 108010045758 lysosomal proteins Proteins 0.000 description 1
• 235000009973 maize Nutrition 0.000 description 1
• 230000003211 malignant effect Effects 0.000 description 1
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 208000024393 maple syrup urine disease Diseases 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 210000001073 mediodorsal thalamic nucleus Anatomy 0.000 description 1
• 210000001767 medulla oblongata Anatomy 0.000 description 1
• 239000012528 membrane Substances 0.000 description 1
• 230000005499 meniscus Effects 0.000 description 1
• 210000001259 mesencephalon Anatomy 0.000 description 1
• 230000002503 metabolic effect Effects 0.000 description 1
• MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
• 108091070501 miRNA Proteins 0.000 description 1
• 238000012737 microarray-based gene expression Methods 0.000 description 1
• 235000021243 milk fat Nutrition 0.000 description 1
• 230000000116 mitigating effect Effects 0.000 description 1
• 230000002438 mitochondrial effect Effects 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 239000007932 molded tablet Substances 0.000 description 1
• 238000009126 molecular therapy Methods 0.000 description 1
• SLZIZIJTGAYEKK-CIJSCKBQSA-N molport-023-220-247 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CN)[C@@H](C)O)C1=CNC=N1 SLZIZIJTGAYEKK-CIJSCKBQSA-N 0.000 description 1
• 208000005264 motor neuron disease Diseases 0.000 description 1
• 201000002273 mucopolysaccharidosis II Diseases 0.000 description 1
• 208000012253 mucopolysaccharidosis IVA Diseases 0.000 description 1
• 208000010978 mucopolysaccharidosis type 4 Diseases 0.000 description 1
• 238000002887 multiple sequence alignment Methods 0.000 description 1
• 238000012243 multiplex automated genomic engineering Methods 0.000 description 1
• 208000010805 mumps infectious disease Diseases 0.000 description 1
• 201000000585 muscular atrophy Diseases 0.000 description 1
• 238000002703 mutagenesis Methods 0.000 description 1
• 231100000350 mutagenesis Toxicity 0.000 description 1
• 206010028417 myasthenia gravis Diseases 0.000 description 1
• 201000000050 myeloid neoplasm Diseases 0.000 description 1
• 210000003098 myoblast Anatomy 0.000 description 1
• 230000002107 myocardial effect Effects 0.000 description 1
• 210000001087 myotubule Anatomy 0.000 description 1
• 230000007498 myristoylation Effects 0.000 description 1
• DDOVBCWVTOHGCU-QMXMISKISA-N n-[(e,2s,3r)-3-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxynonadec-4-en-2-yl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@H]([C@H](O)\C=C\CCCCCCCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O DDOVBCWVTOHGCU-QMXMISKISA-N 0.000 description 1
• 210000004897 n-terminal region Anatomy 0.000 description 1
• 210000000478 neocortex Anatomy 0.000 description 1
• 230000008764 nerve damage Effects 0.000 description 1
• 229940053128 nerve growth factor Drugs 0.000 description 1
• 230000008043 neural expression Effects 0.000 description 1
• 239000004090 neuroprotective agent Substances 0.000 description 1
• 239000002858 neurotransmitter agent Substances 0.000 description 1
• 230000002276 neurotropic effect Effects 0.000 description 1
• 230000003472 neutralizing effect Effects 0.000 description 1
• 239000000346 nonvolatile oil Substances 0.000 description 1
• 108020004017 nuclear receptors Proteins 0.000 description 1
• 230000030648 nucleus localization Effects 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 239000007764 o/w emulsion Substances 0.000 description 1
• 235000020824 obesity Nutrition 0.000 description 1
• 210000000869 occipital lobe Anatomy 0.000 description 1
• 230000003565 oculomotor Effects 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 235000019198 oils Nutrition 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 239000004006 olive oil Substances 0.000 description 1
• 235000008390 olive oil Nutrition 0.000 description 1
• 210000003977 optic chiasm Anatomy 0.000 description 1
• 210000005112 optic tract Anatomy 0.000 description 1
• 230000004421 optic tracts Effects 0.000 description 1
• 150000002895 organic esters Chemical class 0.000 description 1
• 230000008723 osmotic stress Effects 0.000 description 1
• 210000000963 osteoblast Anatomy 0.000 description 1
• 230000002018 overexpression Effects 0.000 description 1
• 208000027753 pain disease Diseases 0.000 description 1
• 201000002528 pancreatic cancer Diseases 0.000 description 1
• 208000008443 pancreatic carcinoma Diseases 0.000 description 1
• 230000003071 parasitic effect Effects 0.000 description 1
• 238000007911 parenteral administration Methods 0.000 description 1
• 230000001936 parietal effect Effects 0.000 description 1
• 210000001152 parietal lobe Anatomy 0.000 description 1
• 239000006072 paste Substances 0.000 description 1
• 235000010603 pastilles Nutrition 0.000 description 1
• 210000000062 pectoralis major Anatomy 0.000 description 1
• 210000000989 pectoralis minor Anatomy 0.000 description 1
• 210000004197 pelvis Anatomy 0.000 description 1
• 229940111202 pepsin Drugs 0.000 description 1
• 210000002509 periaqueductal gray Anatomy 0.000 description 1
• 210000002640 perineum Anatomy 0.000 description 1
• 230000000737 periodic effect Effects 0.000 description 1
• 230000002688 persistence Effects 0.000 description 1
• 230000002085 persistent effect Effects 0.000 description 1
• 235000019271 petrolatum Nutrition 0.000 description 1
• 238000002823 phage display Methods 0.000 description 1
• 239000008177 pharmaceutical agent Substances 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
• 239000003934 phosphoprotein phosphatase inhibitor Substances 0.000 description 1
• 102000020233 phosphotransferase Human genes 0.000 description 1
• 210000004560 pineal gland Anatomy 0.000 description 1
• 210000003635 pituitary gland Anatomy 0.000 description 1
• 208000010916 pituitary tumor Diseases 0.000 description 1
• 239000004033 plastic Substances 0.000 description 1
• 229920003023 plastic Polymers 0.000 description 1
• 108700004029 pol Genes Proteins 0.000 description 1
• 229920002223 polystyrene Polymers 0.000 description 1
• 239000011148 porous material Substances 0.000 description 1
• 230000004481 post-translational protein modification Effects 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 238000009609 prenatal screening Methods 0.000 description 1
• 230000013823 prenylation Effects 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
• 230000000861 pro-apoptotic effect Effects 0.000 description 1
• 201000008752 progressive muscular atrophy Diseases 0.000 description 1
• 230000035755 proliferation Effects 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 108060006633 protein kinase Proteins 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• 210000002637 putamen Anatomy 0.000 description 1
• 239000013646 rAAV2 vector Substances 0.000 description 1
• 210000001609 raphe nuclei Anatomy 0.000 description 1
• 238000010188 recombinant method Methods 0.000 description 1
• 210000000463 red nucleus Anatomy 0.000 description 1
• 238000009256 replacement therapy Methods 0.000 description 1
• 210000003994 retinal ganglion cell Anatomy 0.000 description 1
• 230000007441 retrograde transport Effects 0.000 description 1
• 230000001177 retroviral effect Effects 0.000 description 1
• 108700004030 rev Genes Proteins 0.000 description 1
• 102000000568 rho-Associated Kinases Human genes 0.000 description 1
• 108010041788 rho-Associated Kinases Proteins 0.000 description 1
• 210000003705 ribosome Anatomy 0.000 description 1
• 201000005404 rubella Diseases 0.000 description 1
• 201000000980 schizophrenia Diseases 0.000 description 1
• 230000003248 secreting effect Effects 0.000 description 1
• 230000028327 secretion Effects 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 229940126586 small molecule drug Drugs 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 208000020431 spinal cord injury Diseases 0.000 description 1
• 201000003624 spinocerebellar ataxia type 1 Diseases 0.000 description 1
• 210000001324 spliceosome Anatomy 0.000 description 1
• 239000007921 spray Substances 0.000 description 1
• 230000006641 stabilisation Effects 0.000 description 1
• 238000011105 stabilization Methods 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 150000003431 steroids Chemical class 0.000 description 1
• 201000011549 stomach cancer Diseases 0.000 description 1
• 230000035882 stress Effects 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 210000004281 subthalamic nucleus Anatomy 0.000 description 1
• 239000006228 supernatant Substances 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 239000004094 surface-active agent Substances 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 239000000375 suspending agent Substances 0.000 description 1
• 238000013268 sustained release Methods 0.000 description 1
• 239000012730 sustained-release form Substances 0.000 description 1
• 230000008961 swelling Effects 0.000 description 1
• 210000001258 synovial membrane Anatomy 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 238000012385 systemic delivery Methods 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 101150047061 tag-72 gene Proteins 0.000 description 1
• 210000001587 telencephalon Anatomy 0.000 description 1
• 210000003478 temporal lobe Anatomy 0.000 description 1
• 201000003120 testicular cancer Diseases 0.000 description 1
• 108700020534 tetracycline resistance-encoding transposon repressor Proteins 0.000 description 1
• 230000000542 thalamic effect Effects 0.000 description 1
• 210000001103 thalamus Anatomy 0.000 description 1
• 239000002562 thickening agent Substances 0.000 description 1
• 230000002992 thymic effect Effects 0.000 description 1
• 208000008732 thymoma Diseases 0.000 description 1
• LCJVIYPJPCBWKS-NXPQJCNCSA-N thymosin Chemical compound SC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CO)C(=O)N[C@H](CO)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(O)=O)C(O)=O LCJVIYPJPCBWKS-NXPQJCNCSA-N 0.000 description 1
• 201000002510 thyroid cancer Diseases 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 239000000196 tragacanth Substances 0.000 description 1
• 235000010487 tragacanth Nutrition 0.000 description 1
• 229940116362 tragacanth Drugs 0.000 description 1
• 230000005030 transcription termination Effects 0.000 description 1
• 108091006106 transcriptional activators Proteins 0.000 description 1
• 238000001890 transfection Methods 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 238000011820 transgenic animal model Methods 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• 230000008733 trauma Effects 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• 102000003390 tumor necrosis factor Human genes 0.000 description 1
• 230000004222 uncontrolled growth Effects 0.000 description 1
• 241001430294 unidentified retrovirus Species 0.000 description 1
• 230000003827 upregulation Effects 0.000 description 1
• 201000005112 urinary bladder cancer Diseases 0.000 description 1
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
• 238000010200 validation analysis Methods 0.000 description 1
• 210000005166 vasculature Anatomy 0.000 description 1
• 235000015112 vegetable and seed oil Nutrition 0.000 description 1
• 239000008158 vegetable oil Substances 0.000 description 1
• 230000023898 viral genome packaging Effects 0.000 description 1
• 230000009385 viral infection Effects 0.000 description 1
• 239000007762 w/o emulsion Substances 0.000 description 1
• 239000008215 water for injection Substances 0.000 description 1
• 230000003442 weekly effect Effects 0.000 description 1
• 229940051021 yellow-fever virus Drugs 0.000 description 1